Knowledge

Antiviral drug

Source 📝

913:(Rapivab). Influenza antiviral resistance often results from changes occurring in neuraminidase and hemagglutinin proteins on the viral surface. Currently, neuraminidase inhibitors (NAIs) are the most frequently prescribed antivirals because they are effective against both influenza A and B. However, antiviral resistance is known to develop if mutations to the neuraminidase proteins prevent NAI binding. This was seen in the H257Y mutation, which was responsible for oseltamivir resistance to H1N1 strains in 2009. The inability of NA inhibitors to bind to the virus allowed this strain of virus with the resistance mutation to spread due to natural selection. Furthermore, a study published in 2009 in 36: 938:
less than 30 kb, which allow them to sustain a high frequency of mutations. DNA viruses, such as HPV and herpesvirus, hijack host cell replication machinery, which gives them proofreading capabilities during replication. DNA viruses are therefore less error prone, are generally less diverse, and are more slowly evolving than RNA viruses. In both cases, the likelihood of mutations is exacerbated by the speed with which viruses reproduce, which provides more opportunities for mutations to occur in successive replications. Billions of viruses are produced every day during the course of an infection, with each replication giving another chance for mutations that encode for resistance to occur.
980:
viral life cycle. This is frequently used in retroviruses like HIV, but a number of studies have demonstrated its effectiveness against influenza A, as well. Viruses can also be screened for resistance to drugs before treatment is started. This minimizes exposure to unnecessary antivirals and ensures that an effective medication is being used. This may improve patient outcomes and could help detect new resistance mutations during routine scanning for known mutants. However, this has not been consistently implemented in treatment facilities at this time.
5144: 5165: 340:" strategies for developing antivirals have tried to attack viruses at every stage of their life cycles. Some species of mushrooms have been found to contain multiple antiviral chemicals with similar synergistic effects. Compounds isolated from fruiting bodies and filtrates of various mushrooms have broad-spectrum antiviral activities, but successful production and availability of such compounds as frontline antiviral is a long way away. 182: 1174: 284:
should also be common across many strains of a virus, or even among different species of virus in the same family, so a single drug will have broad effectiveness. For example, a researcher might target a critical enzyme synthesized by the virus, but not by the patient, that is common across strains, and see what can be done to interfere with its operation.
433:, or the brand name Fuzeon—has received FDA approval and has been in use for some time. Potentially, one of the benefits from the use of an effective entry-blocking or entry-inhibiting agent is that it potentially may not only prevent the spread of the virus within an infected individual but also the spread from an infected to an uninfected individual. 1116:(LHDs) with access to antivirals, guidelines may be unclear, causing delays in treatment. With time-sensitive therapies, delays could lead to lack of treatment. Overall, national guidelines, regarding infection control and management, standardize care and improve healthcare worker and patient safety. Guidelines, such as those provided by the 862:, protein molecules that can bind to a pathogen and mark it for attack by other elements of the immune system. Once researchers identify a particular target on the pathogen, they can synthesize quantities of identical "monoclonal" antibodies to link up that target. A monoclonal drug is now being sold to help fight 417:, when the virus attaches to and enters the host cell. A number of "entry-inhibiting" or "entry-blocking" drugs are being developed to fight HIV. HIV most heavily targets a specific type of lymphocyte known as "helper T cells", and identifies these target cells through T-cell surface receptors designated " 979:
The most commonly used method for treating resistant viruses is combination therapy, which uses multiple antivirals in one treatment regimen. This is thought to decrease the likelihood that one mutation could cause antiviral resistance, as the antivirals in the cocktail target different stages of the
975:
If a virus is not fully wiped out during a regimen of antivirals, treatment creates a bottleneck in the viral population that selects for resistance, and there is a chance that a resistant strain may repopulate the host. Viral treatment mechanisms must therefore account for the selection of resistant
928:
The genetic makeup of viruses is constantly changing, which can cause a virus to become resistant to currently available treatments. Viruses can become resistant through spontaneous or intermittent mechanisms throughout the course of an antiviral treatment. Immunocompromised patients, more often than
897:
viruses (depending on the vaccination). Comprehensive protection starts by ensuring vaccinations are current and complete. However, vaccines are preventative and are not generally used once a patient has been infected with a virus. Additionally, the availability of these vaccines can be limited based
436:
One possible advantage of the therapeutic approach of blocking viral entry (as opposed to the currently dominant approach of viral enzyme inhibition) is that it may prove more difficult for the virus to develop resistance to this therapy than for the virus to mutate or evolve its enzymatic protocols.
937:
The mechanisms for antiviral resistance development depend on the type of virus in question. RNA viruses such as hepatitis C and influenza A have high error rates during genome replication because RNA polymerases lack proofreading activity. RNA viruses also have small genome sizes that are typically
877:
can be defined by a decreased susceptibility to a drug caused by changes in viral genotypes. In cases of antiviral resistance, drugs have either diminished or no effectiveness against their target virus. The issue inevitably remains a major obstacle to antiviral therapy as it has developed to almost
687:
has been suggested, and ribozyme antivirals are being developed to deal with HIV. An interesting variation of this idea is the use of genetically modified cells that can produce custom-tailored ribozymes. This is part of a broader effort to create genetically modified cells that can be injected into
510:
can cause them too. Rhinoviruses also exacerbate asthma attacks. Although rhinoviruses come in many varieties, they do not drift to the same degree that influenza viruses do. A mixture of 50 inactivated rhinovirus types should be able to stimulate neutralizing antibodies against all of them to some
156:
drug discovery methods. Researchers grew cultures of cells and infected them with the target virus. They then introduced into the cultures chemicals which they thought might inhibit viral activity and observed whether the level of virus in the cultures rose or fell. Chemicals that seemed to have an
1161:
prepare for shortages of antiviral medications in cases of public health emergencies. During the H1N1 pandemic in 2009–2010, guidelines for SNS use by local health departments was unclear, revealing gaps in antiviral planning. For example, local health departments that received antivirals from the
919:
emphasized the urgent need for augmentation of oseltamivir stockpiles with additional antiviral drugs including zanamivir. This finding was based on a performance evaluation of these drugs supposing the 2009 H1N1 'Swine Flu' neuraminidase (NA) were to acquire the oseltamivir-resistance (His274Tyr)
428:
HIV infects a cell through fusion with the cell membrane, which requires two different cellular molecular participants, CD4 and a chemokine receptor (differing depending on the cell type). Approaches to blocking this virus/cell fusion have shown some promise in preventing entry of the virus into a
140:
The emergence of antivirals is the product of a greatly expanded knowledge of the genetic and molecular function of organisms, allowing biomedical researchers to understand the structure and function of viruses, major advances in the techniques for finding new drugs, and the pressure placed on the
283:
The general idea behind modern antiviral drug design is to identify viral proteins, or parts of proteins, that can be disabled. These "targets" should generally be as unlike any proteins or parts of proteins in humans as possible, to reduce the likelihood of side effects and toxicity. The targets
3751:
Yoshida, Eric M.; Sulkowski, Mark S.; Gane, Edward J.; Herring, Robert W.; Ratziu, Vlad; Ding, Xiao; Wang, Jing; Chuang, Shu‐Min; Ma, Julie; McNally, John; Stamm, Luisa M.; Brainard, Diana M.; Symonds, William T.; McHutchison, John G.; Beavers, Kimberly L.; Jacobson, Ira M.; Reddy, K. Rajender;
1111:
Guidelines regarding viral diagnoses and treatments change frequently and limit quality care. Even when physicians diagnose older patients with influenza, use of antiviral treatment can be low. Provider knowledge of antiviral therapies can improve patient care, especially in geriatric medicine.
620:
Genomics has not only helped find targets for many antivirals, it has provided the basis for an entirely new type of drug, based on "antisense" molecules. These are segments of DNA or RNA that are designed as complementary molecule to critical sections of viral genomes, and the binding of these
3828:
van der Meer, Adriaan J.; Veldt, Bart J.; Feld, Jordan J.; Wedemeyer, Heiner; Dufour, Jean-François; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E. Jenny; Manns, Michael P.; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W. Peter; de Knegt, Robert J.; Hansen, Bettina E.; Janssen, Harry L. A. (26
966:
further recommends in-depth epidemiological investigations to control potential transmission of the resistant virus and prevent future progression. As novel treatments and detection techniques to antiviral resistance are enhanced so can the establishment of strategies to combat the inevitable
488:
Some scientists are making the case that a vaccine against rhinoviruses, the predominant cause of the common cold, is achievable. Vaccines that combine dozens of varieties of rhinovirus at once are effective in stimulating antiviral antibodies in mice and monkeys, researchers reported in
372:" molecule on the surface of the host cell and ending with the virus "uncoating" inside the cell and releasing its contents. Viruses that have a lipid envelope must also fuse their envelope with the target cell, or with a vesicle that transports them into the cell before they can uncoat. 847:
Rather than attacking viruses directly, a second category of tactics for fighting viruses involves encouraging the body's immune system to attack them. Some antivirals of this sort do not focus on a specific pathogen, instead stimulating the immune system to attack a range of pathogens.
136:
Viruses use the host's cells to replicate and this makes it difficult to find targets for the drug that would interfere with the virus without also harming the host organism's cells. Moreover, the major difficulty in developing vaccines and antiviral drugs is due to viral variation.
712:" to attack HIV at that phase of its life cycle. Protease inhibitors became available in the 1990s and have proven effective, though they can have unusual side effects, for example causing fat to build up in unusual places. Improved protease inhibitors are now in development. 855:, which inhibit viral synthesis in infected cells. One form of human interferon named "interferon alpha" is well-established as part of the standard treatment for hepatitis B and C, and other interferons are also being investigated as treatments for various diseases. 793:
selectively in virus-infected mammalian cells, while leaving uninfected cells unharmed. DRACO effects cell death via one of the last steps in the apoptosis pathway in which complexes containing intracellular apoptosis signalling molecules simultaneously bind multiple
945:, results in immense variation in any given sample of virus, and gives the opportunity for natural selection to favor viral strains with the highest fitness every time the virus is spread to a new host. Recombination, the joining of two different viral variants, and 961:
National and international surveillance is performed by the CDC to determine effectiveness of the current FDA-approved antiviral flu drugs. Public health officials use this information to make current recommendations about the use of flu antiviral medications.
1062:
remains undetectable 12–24 weeks after treatment ends. Whether through DAAs or older interferon-based regimens, SVR is associated with improved health outcomes and significantly decreased mortality. For those who already have advanced liver disease (including
680:, which are enzymes that will cut apart viral RNA or DNA at selected sites. In their natural course, ribozymes are used as part of the viral manufacturing sequence, but these synthetic ribozymes are designed to cut RNA and DNA at sites that will disable them. 425:". Attempts to interfere with the binding of HIV with the CD4 receptor have failed to stop HIV from infecting helper T cells, but research continues on trying to interfere with the binding of HIV to the CCR5 receptor in hopes that it will be more effective. 2609:
Suzuki H, Okubo A, Yamazaki S, Suzuki K, Mitsuya H, Toda S (1989). "Inhibition of the infectivity and cytopathic effect of human immunodeficiency virus by water-soluble lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM)".
565:, has been approved to treat hepatitis B, which uses reverse transcriptase as part of its replication process. Researchers have gone further and developed inhibitors that do not look like nucleosides, but can still block reverse transcriptase. 933:
are at the highest risk of developing oseltamivir resistance during treatment. Subsequent to exposure to someone else with the flu, those who received oseltamivir for "post-exposure prophylaxis" are also at higher risk of resistance.
1612:
Wu, Gaochan; Zhao, Tong; Kang, Dongwei; Zhang, Jian; Song, Yuning; Namasivayam, Vigneshwaran; Kongsted, Jacob; Pannecouque, Christophe; De Clercq, Erik; Poongavanam, Vasanthanathan; Liu, Xinyong; Zhan, Peng (14 November 2019).
3855:
Backus, Lisa I.; Belperio, Pamela S.; Shahoumian, Troy A.; Mole, Larry A. (February 2019). "Impact of Sustained Virologic Response with Direct‐Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease".
952:
Antiviral resistance has been reported in antivirals for herpes, HIV, hepatitis B and C, and influenza, but antiviral resistance is a possibility for all viruses. Mechanisms of antiviral resistance vary between virus types.
398:
This strategy of designing drugs can be very expensive, and since the process of generating anti-idiotypic antibodies is partly trial and error, it can be a relatively slow process until an adequate molecule is produced.
5649: 302:
or other kinds of cells. The cells are then cultured for mass production of the protein, which can then be exposed to various treatment candidates and evaluated with "rapid screening" technologies.
160:
This was a very time-consuming, hit-or-miss procedure, and in the absence of a good knowledge of how the target virus worked, it was not efficient in discovering effective antivirals which had few
333:
layer (sometimes called an 'envelope'). Viruses cannot reproduce on their own and instead propagate by subjugating a host cell to produce copies of themselves, thus producing the next generation.
3969:
Lindegren, Mary Louise; Griffin, Marie R.; Williams, John V.; Edwards, Kathryn M.; Zhu, Yuwei; Mitchel, Ed; Fry, Alicia M.; Schaffner, William; Talbot, H. Keipp; Pyrc, Krzysztof (25 March 2015).
1070:
Despite its historical roots in hepatitis C research, the term "direct-acting antivirals" is becoming more broadly used to also include other anti-viral drugs with a direct viral target such as
1162:
SNS did not have transparent guidance on the use of the treatments. The gap made it difficult to create plans and policies for their use and future availabilities, causing delays in treatment.
368:
One antiviral strategy is to interfere with the ability of a virus to infiltrate a target cell. The virus must go through a sequence of steps to do this, beginning with binding to a specific "
287:
Once targets are identified, candidate drugs can be selected, either from drugs already known to have appropriate effects or by actually designing the candidate at the molecular level with a
6682: 5623: 3128:
Nijhuis, M; van Maarseveen, NM; Boucher, CA (2009). "Antiviral Resistance and Impact on Viral Replication Capacity: Evolution of Viruses Under Antiviral Pressure Occurs in Three Phases".
6645: 5541: 3085:
Soundararajan, V; Tharakaraman, K; Raman, R; Raguram, S; Shriver, Z; Sasisekharan, V; Sasisekharan, R (June 2009). "Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus".
1012:) of hepatitis C virus that are causing the infection. Both during and at the end of treatment, blood tests are used to monitor the effectiveness of the treatment and subsequent cure. 821:
The final stage in the life cycle of a virus is the release of completed viruses from the host cell, and this step has also been targeted by antiviral drug developers. Two drugs named
3787:"Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response" 1149:
initiatives are managed by the CDC via the Office of Public Health Preparedness and Response. Funds aim to support communities in preparing for public health emergencies, including
708:
that cuts viral protein chains apart so they can be assembled into their final configuration. HIV includes a protease, and so considerable research has been performed to find "
941:
Multiple strains of one virus can be present in the body at one time, and some of these strains may contain mutations that cause antiviral resistance. This effect, called the
3883:
Kleandrova VV, Scotti MT, Speck-Planche A (2021). "Indirect-Acting Pan-Antivirals vs. Respiratory Viruses: A Fresh Perspective on Computational Multi-Target Drug Discovery".
5643: 168:
of viruses began to be unraveled, did researchers begin to learn how viruses worked in detail, and exactly what chemicals were needed to thwart their reproductive cycle.
5833: 1850:
Pradeep, Prabin; Manju, Vidya; Ahsan, Mohammad Feraz (2019), Agrawal, Dinesh Chandra; Dhanasekaran, Muralikrishnan (eds.), "Antiviral Potency of Mushroom Constituents",
4080: 5838: 7585: 5784: 1158: 1574: 543:, but deactivate the enzymes that synthesize the RNA or DNA once the analogue is incorporated. This approach is more commonly associated with the inhibition of 5256: 1400:
Schnitzler, P; Schön, K; Reichling, J (2001). "Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture".
1198: 93:, which are not medication but deactivate or destroy virus particles, either inside or outside the body. Natural virucides are produced by some plants such as 8469: 6223: 5096: 4176: 5420: 4032: 3169: 2147:
Deas, T. S.; Binduga-Gajewska, I.; Tilgner, M.; Ren, P.; Stein, D. A.; Moulton, H. M.; Iversen, P. L.; Kauffman, E. B.; Kramer, L. D.; Shi, P. -Y. (2005).
2112:
Stein DA, Skilling DE, Iversen PL, Smith AW (2001). "Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers".
2570:"The inhibitory properties and primary structure of a novel serine proteinase inhibitor from the fruiting body of the basidiomycete, Lentinus edodes" 1132:
guidelines for exposed persons. Roles of pharmacists and pharmacies have also expanded to meet the needs of public during public health emergencies.
4144: 5790: 1008:(indirect acting). The DAA drugs against hepatitis C are taken orally, as tablets, for 8 to 12 weeks. The treatment depends on the type or types ( 469:, by blocking a pocket on the surface of the virus that controls the uncoating process. This pocket is similar in most strains of rhinoviruses and 3831:"Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis" 3694: 5848: 5768: 5153: 561:
An improved knowledge of the action of reverse transcriptase has led to better nucleoside analogues to treat HIV infections. One of these drugs,
8907: 5853: 6972: 5801: 5202: 1113: 3754:"Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus" 8461: 7578: 5823: 5807: 1228: 7113: 6176: 6171: 4166: 7036: 5818: 4947: 1573:
Bryan-Marrugo, O. L.; Ramos-Jiménez, J.; Barrera-Saldaña, H.; Rojas-Martínez, A.; Vidaltamayo, R.; Rivas-Estilla, A. M. (1 July 2015).
1117: 1094:). In this context it serves to distinguish these drugs from those with an indirect mechanism of action such as immune modulators like 886: 554:, is a nucleoside analogue, and is effective against herpesvirus infections. The first antiviral drug to be approved for treating HIV, 4907: 2071: 1128:, recommend, among other things, antiviral treatment regimens, clinical assessment algorithms for coordination of care, and antiviral 688:
a host to attack pathogens by generating specialized proteins that block viral replication at various phases of the viral life cycle.
5828: 629:, and other antisense antivirals are in development. An antisense structural type that has proven especially valuable in research is 2521:"The Role of Protease Inhibitors in the Pathogenesis of HIV-Associated Lipodystrophy: Cellular Mechanisms and Clinical Implications" 829:(Tamiflu) that have been recently introduced to treat influenza prevent the release of viral particles by blocking a molecule named 6852: 6262: 6095: 3710:"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits" 1730:
Bobrowski T, Melo-Filho CC, Korn D, Alves VM, Popov KI, Auerbach S, Schmitt C, Moorman NJ, Muratov EN, Tropsha A (September 2020).
1673:"Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary" 898:
on financial or locational reasons which can prevent the effectiveness of herd immunity, making effective antivirals a necessity.
7571: 5739: 9242: 9229: 7843: 7599: 2892: 1779: 1341:
Ko K, Tekoah Y, Rudd PM, Harvey DJ, Dwek RA, Spitsin S, Hanlon CA, Rupprecht C, Dietzschold B, Golovkin M, Koprowski H (2003).
949:, the swapping of viral gene segments among viruses in the same cell, also play a role in resistance, especially in influenza. 1427:
Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, Akram M, Riaz M, Rasool G, Hamid Khan A, Saleem I, Shamim S, Malik A (2021).
8514: 7529: 6796: 6194: 6085: 4520: 3145: 2485: 1991: 1867: 1547: 762: 246: 7856: 2519:
Flint, O. P.; Noor, M. A.; Hruz, P. W.; Hylemon, P. B.; Yarasheski, K.; Kotler, D. P.; Parker, R. A.; Bellamine, A. (2009).
9031: 8489: 4807: 4800: 2294:
Neuman, B. W.; Stein, D. A.; Kroeker, A. D.; Paulino, A. D.; Moulton, H. M.; Iversen, P. L.; Buchmeier, M. J. (June 2004).
2149:"Inhibition of Flavivirus Infections by Antisense Oligomers Specifically Suppressing Viral Translation and RNA Replication" 1146: 621:
antisense segments to these target sections blocks the operation of those genomes. A phosphorothioate antisense drug named
218: 1671:
Xu, Shujing; Ding, Dang; Zhang, Xujie; Sun, Lin; Kang, Dongwei; Huang, Boshi; Liu, Xinyong; Zhan, Peng (27 January 2022).
901:
The three FDA-approved neuraminidase antiviral flu drugs available in the United States, recommended by the CDC, include:
8168: 7174: 5843: 5180: 141:
medical profession to deal with the human immunodeficiency virus (HIV), the cause of acquired immunodeficiency syndrome (
2296:"Antisense Morpholino-Oligomers Directed against the 5' End of the Genome Inhibit Coronavirus Proliferation and Growth†" 9234: 5858: 4550: 4413: 1233: 8238: 343:
Viral life cycles vary in their precise details depending on the type of virus, but they all share a general pattern:
225: 8664: 8659: 7159: 6322: 5414: 5195: 4174: 2384:
Bai J, Rossi J, Akkina R (March 2001). "Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy".
1935:"Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles" 709: 696:
Interference with post translational modifications or with targeting of viral proteins in the cell is also possible.
379:
Using agents which mimic the virus-associated protein (VAP) and bind to the cellular receptors. This may include VAP
265: 8269: 3250:"The relationship between mutation frequency and replication strategy in positive sense single-stranded RNA viruses" 9203: 8743: 8150: 7766: 7546: 6813: 6211: 5868: 5752: 608:(mRNA) molecules that direct the synthesis of viral proteins. Production of mRNA is initiated by proteins known as 1575:"History and progress of antiviral drugs: From acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C" 8337: 5878: 5863: 5526: 5514: 4703: 4159: 3177: 2196:
Kinney, R. M.; Huang, C. Y.-H.; Rose, B. C.; Kroeker, A. D.; Dreher, T. W.; Iversen, P. L.; Stein, D. A. (2005).
765:. In cell culture, DRACO was reported to have broad-spectrum efficacy against many infectious viruses, including 199: 4039: 2345:"Identification of the most accessible sites to ribozymes on the hepatitis C virus internal ribosome entry site" 232: 9078: 8676: 8395: 8373: 7804: 5758: 1125: 833:
that is found on the surface of flu viruses, and also seems to be constant across a wide range of flu strains.
203: 9046: 7744: 6830: 6240: 572:—which is a component of reverse transcriptase that splits the synthesized DNA from the original viral RNA. 519:
A second approach is to target the processes that synthesize virus components after a virus invades a cell.
35: 9073: 8226: 7989: 7704: 6845: 6255: 5188: 4402: 4184: 3223: 1154: 1141: 1051: 866:
in babies, and antibodies purified from infected individuals are also used as a treatment for hepatitis B.
214: 7898: 2848:
Nokes JD, Cane PA (December 2008). "New strategies for control of respiratory syncytial virus infection".
889:(CDC) inclusively recommends anyone six months and older to get a yearly vaccination to protect them from 584:, which integrate the synthesized DNA into the host cell genome. Examples of integrase inhibitors include 9115: 8986: 8922: 8890: 8838: 8135: 8117: 5013: 863: 499: 27: 3920:"Challenges of the Pandemic Response in Primary Care during Pre-Vaccination Period: A Qualitative Study" 2709:"Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65" 8671: 8084: 7824: 4663: 4152: 612:. Several antivirals are now being designed to block attachment of transcription factors to viral DNA. 20: 3785:
Simmons, Bryony; Saleem, Jawaad; Heath, Katherine; Cooke, Graham S.; Hill, Andrew (1 September 2015).
2421:"Megalomycin C, a macrolide antibiotic that blocks protein glycosylation and shows antiviral activity" 9175: 9165: 8860: 8796: 8519: 8484: 8287: 8264: 8050: 7863: 1530:
Bule, Mohammed; Khan, Fazlullah; Niaz, Kamal (6 June 2019). "Antivirals: Past, Present and Future".
9290: 8993: 8855: 8730: 8584: 7699: 7689: 7149: 6295: 6035: 5945: 5813: 5774: 1064: 874: 59: 9180: 9098: 8964: 8494: 8292: 7999: 7937: 7771: 7739: 7534: 7286: 6838: 6801: 6248: 6199: 5795: 4718: 4396: 4247: 1209: 1098:. This difference is of particular relevance for potential drug resistance mutation development. 1058:
called sustained virological response (SVR). SVR is achieved in a patient when hepatitis C virus
192: 7851: 3918:
Kunin, Marina; Engelhard, Dan; Thomas, Shane; Ashworth, Mark; Piterman, Leon (15 October 2015).
8767: 8552: 8302: 8175: 7781: 7638: 7628: 7398: 7383: 7169: 7164: 6416: 5873: 4755: 4510: 82:. Most antivirals are considered relatively harmless to the host, and therefore can be used to 715:
Protease inhibitors have also been seen in nature. A protease inhibitor was isolated from the
9088: 8720: 8589: 8097: 8004: 7923: 7345: 7340: 7154: 6748: 6697: 6553: 6070: 5883: 5763: 5633: 5232: 4440: 4376: 4221: 2198:"Inhibition of Dengue Virus Serotypes 1 to 4 in Vero Cell Cultures with Morpholino Oligomers" 1193: 1157:(SNS) consists of bulk quantities of medicines and supplies for use during such emergencies. 544: 491: 288: 79: 7868: 3830: 1067:), however, the benefits of achieving SVR may be less pronounced, though still substantial. 294:
The target proteins can be manufactured in the lab for testing with candidate treatments by
239: 9170: 9063: 9009: 8937: 8927: 8619: 8474: 8347: 7954: 7563: 7144: 6692: 6549: 5953: 5779: 5628: 5386: 4515: 4495: 4364: 3982: 2965: 2658: 2075: 1354: 1075: 915: 625:
has been introduced, used to treat opportunistic eye infections in AIDS patients caused by
609: 390:
Using agents which mimic the cellular receptor and bind to the VAP. This includes anti-VAP
337: 149: 5210: 3645:
Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS (May 2017).
8: 9257: 9247: 9213: 8818: 8256: 8092: 7903: 6678: 6641: 6393: 5888: 5747: 5619: 5537: 5336: 5215: 5124: 4860: 4646: 4425: 4252: 3593: 2247:"A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice" 1204: 1187: 503: 455:
have been introduced to combat influenza. These agents act on penetration and uncoating.
295: 98: 3986: 3594:
Gonzålez-Grande R, Jiménez-Pérez M, Gonzålez Arjona C, Mostazo Torres J (January 2016).
3038: 2662: 1890:
Bishop NE (1998). "Examination of potential inhibitors of hepatitis A virus uncoating".
1614: 1358: 394:, receptor anti-idiotypic antibodies, extraneous receptor and synthetic receptor mimics. 8981: 8976: 8885: 8865: 8499: 8342: 8307: 8161: 8127: 7677: 7335: 7240: 6743: 5158: 5023: 4882: 4336: 4005: 3970: 3946: 3919: 3813: 3786: 3736: 3709: 3671: 3647:"Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review" 3646: 3622: 3595: 3554: 3529: 3510: 3456: 3431: 3363: 3338: 3274: 3249: 3110: 3014: 2989: 2920: 2873: 2830: 2681: 2646: 2545: 2520: 2496: 2450: 2276: 2222: 2197: 2173: 2148: 2058:"A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" 1915: 1873: 1827: 1802: 1756: 1731: 1707: 1672: 1650: 1572: 1558: 1504: 1477: 1453: 1428: 1303: 1276: 1150: 1055: 942: 369: 7913: 3896: 2733: 2708: 2320: 2295: 1959: 1934: 1377: 1342: 9295: 9267: 9208: 9068: 9021: 8823: 8325: 7994: 7984: 7974: 7959: 7776: 7759: 7623: 7496: 6030: 5693: 5164: 5119: 4902: 4892: 4795: 4625: 4581: 4565: 4369: 4359: 4302: 4292: 4010: 3951: 3900: 3676: 3627: 3559: 3514: 3502: 3461: 3409: 3368: 3319: 3279: 3151: 3141: 3102: 3060: 3019: 2912: 2865: 2834: 2822: 2787: 2782: 2757: 2738: 2686: 2627: 2623: 2591: 2586: 2569: 2550: 2501: 2481: 2442: 2437: 2420: 2401: 2366: 2325: 2311: 2268: 2227: 2178: 2129: 2038: 2033: 2008: 1987: 1964: 1907: 1877: 1863: 1832: 1761: 1712: 1694: 1654: 1642: 1634: 1594: 1543: 1509: 1458: 1409: 1382: 1308: 1257: 1121: 802:
in the cascade, and cleave a variety of cellular proteins, thereby killing the cell.
723:). The presence of this may explain the Shiitake mushrooms' noted antiviral activity 660: 3114: 3039:"Targeting pandemic influenza: a primer on influenza antivirals and drug resistance" 2928: 2924: 2724: 2454: 2213: 2164: 1950: 1919: 1293: 9262: 9198: 9185: 9014: 9003: 8895: 8875: 8710: 8624: 8599: 8330: 8277: 8216: 8107: 7754: 7682: 7355: 6055: 5129: 4952: 4877: 4865: 4790: 4656: 4535: 4324: 4123: 4000: 3990: 3941: 3931: 3892: 3865: 3808: 3798: 3765: 3731: 3721: 3666: 3658: 3617: 3607: 3549: 3541: 3492: 3451: 3443: 3399: 3358: 3350: 3309: 3269: 3261: 3133: 3094: 3050: 3009: 3001: 2904: 2877: 2857: 2814: 2777: 2769: 2728: 2720: 2676: 2666: 2619: 2581: 2540: 2532: 2491: 2473: 2432: 2393: 2356: 2315: 2307: 2280: 2258: 2217: 2209: 2168: 2160: 2121: 2028: 2020: 1954: 1946: 1899: 1855: 1822: 1814: 1751: 1743: 1702: 1684: 1626: 1586: 1553: 1535: 1499: 1489: 1448: 1440: 1372: 1362: 1298: 1288: 1129: 165: 148:
The first experimental antivirals were developed in the 1960s, mostly to deal with
130: 126: 6229: 4596: 4065: 4033:
Public Health Use and Distribution of Antivirals: NACCHO Think Tank Meeting Report
3388:"Antiviral resistance: mechanisms, clinical significance, and future implications" 2773: 9130: 9125: 8969: 8917: 8725: 8702: 8547: 8524: 7908: 7873: 7749: 7694: 6876: 6872: 6570: 6332: 6286: 6282: 6131: 6090: 5250: 5169: 5114: 4983: 4978: 4817: 4750: 4745: 4631: 4577: 4418: 4309: 4262: 3995: 3137: 2861: 2671: 2468:
Anderson J, Schiffer C, Lee SK, Swanstrom R (2009). "Viral Protease Inhibitors".
2361: 2344: 2098: 1859: 1747: 1630: 1539: 1095: 1083: 842: 649: 626: 498:
Rhinoviruses are the most common cause of the common cold; other viruses such as
408: 153: 83: 51: 7878: 3695:"Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure" 2477: 1981: 676:
Yet another antiviral technique inspired by genomics is a set of drugs based on
9160: 9093: 9036: 8697: 8689: 8614: 8567: 8562: 8509: 8233: 8014: 8009: 7969: 7918: 7883: 7721: 7657: 7540: 7480: 7059: 6807: 6359: 6205: 5148: 5048: 5043: 4897: 4887: 4837: 4822: 4812: 4713: 4708: 4698: 4608: 4560: 4555: 4287: 4242: 4238: 3971:"Antiviral Treatment among Older Adults Hospitalized with Influenza, 2006–2012" 3195: 2908: 2397: 2125: 1219: 1179: 879: 778: 478: 380: 161: 6860: 6270: 3936: 3726: 3545: 3314: 3297: 2057: 1689: 1590: 1494: 1444: 636:
Morpholino oligos have been used to experimentally suppress many viral types:
9284: 9041: 8998: 8957: 8850: 8833: 8791: 8504: 8055: 8024: 7645: 7073: 6725: 6524: 6304: 5971: 5721: 5556: 5442: 5080: 5053: 4912: 4730: 4641: 4621: 4617: 4480: 4408: 4297: 4212: 4098: 3580: 3005: 2536: 1698: 1638: 1598: 830: 754: 605: 114: 75: 63: 62:
is effective against a wide range of viruses. Antiviral drugs are a class of
7891: 3612: 3354: 2263: 2246: 2006: 1367: 9252: 9190: 8952: 8932: 8880: 8828: 8779: 8579: 8529: 8140: 7711: 7455: 7450: 7420: 7394: 7379: 7369: 7206: 7128: 7026: 6977: 6947: 6868: 6764: 6535: 6412: 6350: 6278: 6025: 6015: 5596: 5586: 5404: 5361: 5356: 5351: 5313: 5293: 5223: 5038: 4957: 4693: 4651: 4485: 4475: 4391: 4386: 4081:"Antiviral Distribution and Dispensing A Review of Legal and Policy Issues" 4014: 3955: 3904: 3680: 3631: 3563: 3506: 3465: 3404: 3387: 3372: 3323: 3283: 3265: 3155: 3106: 3064: 2916: 2869: 2826: 2818: 2791: 2704: 2690: 2595: 2554: 2505: 2405: 2370: 2329: 2272: 2231: 2182: 2133: 2042: 1911: 1836: 1765: 1716: 1646: 1513: 1462: 1413: 1386: 1343:"Function and glycosylation of plant-derived antiviral monoclonal antibody" 1312: 1261: 946: 774: 766: 593: 589: 507: 482: 3413: 3132:. Handbook of Experimental Pharmacology. Vol. 189. pp. 299–320. 3023: 2742: 2631: 2446: 2024: 1968: 1818: 1426: 604:
Once a virus genome becomes operational in a host cell, it then generates
9145: 8947: 8870: 8845: 8594: 8574: 8479: 8439: 8363: 7734: 7729: 7650: 7633: 7501: 7475: 7470: 7430: 7425: 7389: 7374: 7364: 7309: 7295: 7277: 7215: 7196: 7188: 7046: 7001: 6996: 6942: 6937: 6932: 6927: 6907: 6885: 6773: 6665: 6631: 6617: 6612: 6407: 6368: 6364: 6355: 6151: 6126: 6065: 6050: 6045: 5709: 5676: 5591: 5571: 5366: 5346: 5325: 5272: 5240: 4922: 4832: 4572: 4525: 4470: 4353: 4319: 3803: 3497: 3480: 3055: 2645:
Rider TH, Zook CE, Boettcher TL, Wick ST, Pancoast JS, Zusman BD (2011).
2472:. Handbook of Experimental Pharmacology. Vol. 189. pp. 85–110. 1801:
Lindequist, Ulrike; Niedermeyer, Timo H. J.; JĂŒlich, Wolf-Dieter (2005).
997: 902: 894: 890: 826: 684: 665: 640: 585: 470: 466: 452: 430: 429:
cell. At least one of these entry inhibitors—a biomimetic peptide called
414: 122: 118: 109:
Most of the antiviral drugs now available are designed to help deal with
3447: 3098: 1732:"Learning from history: do not flatten the curve of antiviral research!" 761:) is a group of experimental antiviral drugs initially developed at the 9083: 9058: 9026: 8803: 8784: 8774: 8762: 8609: 8221: 8193: 8019: 7979: 7511: 7506: 7440: 7327: 7272: 7267: 7262: 7258: 7250: 7220: 7123: 7118: 7108: 7103: 7083: 7068: 7041: 7031: 7021: 7011: 6967: 6962: 6957: 6952: 6922: 6917: 6912: 6778: 6735: 6655: 6604: 6594: 6565: 6529: 6513: 6503: 6462: 6447: 6382: 6156: 6136: 6121: 6116: 6080: 6075: 5989: 5934: 5904: 5716: 5704: 5699: 5671: 5611: 5601: 5576: 5561: 5551: 5500: 5495: 5483: 5467: 5457: 5437: 5399: 5309: 5297: 5289: 5100: 5071: 5029: 4998: 4993: 4932: 4927: 4917: 4855: 4841: 4781: 4736: 4684: 4604: 4600: 4541: 4501: 4456: 4452: 4342: 4278: 4228: 4193: 4189: 3708:
Smith-Palmer, Jayne; Cerri, Karin; Valentine, William (December 2015).
3037:
Moss, Ronald; Davey, Richard; Steigbigel, Roy; Fang, Fang (June 2010).
1223: 1087: 1079: 1005: 1000:
infections. These are the more effective than older treatments such as
859: 852: 810: 782: 770: 744: 645: 630: 622: 562: 555: 532: 528: 474: 462: 458: 448: 206: in this section. Unsourced material may be challenged and removed. 94: 71: 67: 47: 4063: 3869: 3770: 3753: 1903: 1476:
Yin H, Jiang N, Shi W, Chi X, Liu S, Chen JL, Wang S (February 2021).
970: 739:
helices during transcription and replication. In contrast, uninfected
9155: 8634: 7667: 7662: 7595: 7465: 7435: 7305: 7300: 7245: 7231: 7088: 7078: 7016: 6894: 6861: 6769: 6720: 6670: 6660: 6650: 6561: 6518: 6508: 6483: 6437: 6422: 6346: 6271: 6166: 6146: 6141: 6111: 6040: 6020: 5909: 5666: 5581: 5566: 5489: 5462: 5452: 5447: 5394: 5371: 5284: 5008: 4988: 4962: 4937: 4872: 4850: 4678: 4591: 4465: 3662: 3644: 3084: 1326:
Rick Daniels; Leslie H. Nicoll. "Pharmacology – Nursing Management".
1071: 1001: 930: 910: 906: 822: 790: 740: 581: 551: 86: 3248:
Thebaud, G; Chadeouf, J; Morelli, M; McCauley, J; Haydon, D (2010).
181: 9138: 9053: 8629: 8604: 8557: 8102: 7672: 7615: 7006: 6687: 6580: 6457: 6161: 5546: 5109: 4973: 4969: 4942: 4381: 4314: 4233: 2893:"Hepatitis B immune globulin and HBV-related liver transplantation" 2703: 1986:. Hagerstwon, MD: Lippincott Williams & Wilkins. p. 1419. 1214: 1037: 1009: 758: 716: 705: 677: 391: 299: 142: 90: 920:
mutation, which is currently widespread in seasonal H1N1 strains.
798:. The procaspases transactivate via cleavage, activate additional 26:"Antiviral Therapy" redirects here. For the academic journal, see 8942: 8813: 8066: 7460: 7098: 7093: 6431: 6402: 6377: 6341: 6060: 5606: 5376: 5085: 5003: 4668: 4435: 4257: 4207: 3530:"Antiviral Drug Resistance: Mechanisms and Clinical Implications" 1043: 1025: 1019: 799: 795: 569: 322: 1852:
Medicinal Mushrooms: Recent Progress in Research and Development
9150: 8715: 8368: 7964: 7445: 7415: 6442: 6010: 6005: 4767: 4430: 3968: 3197:
Molecular Cell Biology: Viruses – Structure, Function, and Uses
2966:"Influenza Antiviral Drug Resistance| Seasonal Influenza (Flu)" 1277:"Nitazoxanide: a first-in-class broad-spectrum antiviral agent" 1031: 655: 384: 350:
Release of viral genes and possibly enzymes into the host cell.
326: 318: 314: 3827: 3247: 2146: 1615:"Overview of Recent Strategic Advances in Medicinal Chemistry" 1268: 375:
This stage of viral replication can be inhibited in two ways:
8379: 5320: 5067: 4777: 4272: 4099:"Funding and Guidance for State and Local Health Departments" 4085:
Association of State and Territorial Health Officials (ASTHO)
3882: 1982:
Beringer, Paul; Troy, David A.; Remington, Joseph P. (2006).
749: 736: 330: 310: 55: 7593: 3917: 3854: 3127: 2467: 2055: 1780:"A History of Antivirals: Mechanisms, Classes, and Subtypes" 1729: 1173: 547:(RNA to DNA) than with "normal" transcriptase (DNA to RNA). 7832: 7056: 6987: 6898: 5834:
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide
5279: 5267: 4771: 3750: 2245:
McCaffrey AP, Meuse L, Karimi M, Contag CH, Kay MA (2003).
1800: 568:
Another target being considered for HIV antivirals include
422: 356:
Assembly of viral components into complete viral particles.
5839:
Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil
3707: 3429: 2244: 2099:"Development of polyvalent inactivated rhinovirus vaccine" 353:
Replication of viral components using host-cell machinery.
5304: 5219: 3189: 3187: 2608: 2293: 2111: 2007:
Daniel C. Pevear; Tina M. Tull; Martin E. Seipel (1999).
1433:
International Journal of Immunopathology and Pharmacology
1091: 1059: 963: 785:, and was additionally found effective against influenza 540: 536: 418: 110: 5785:
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide
3481:"Global transmission of oseltamivir-resistant influenza" 1399: 1325: 3784: 3036: 2418: 992:(DAA) has long been associated with the combination of 743:
cells generally produce dsRNA helices of fewer than 24
305: 3184: 2644: 2195: 1932: 1478:"Development and Effects of Influenza Antiviral Drugs" 1199:
Discovery and development of CCR5 receptor antagonists
4177:
Anatomical Therapeutic Chemical Classification System
3430:
Irwin, K; Renzette, N; Kowalik, T; Jensen, J (2016).
3170:"WHO | Antiviral use and the risk of drug resistance" 1807:
Evidence-Based Complementary and Alternative Medicine
445:
Inhibitors of uncoating have also been investigated.
2518: 1169: 956: 359:
Release of viral particles to infect new host cells.
2707:; Griffiths G; Ericsson M; Moss B; Doms RW (1994). 2612:
Biochemical and Biophysical Research Communications
2567: 971:
Treatment options for antiviral resistant pathogens
691: 3432:"Antiviral drug resistance as an adaptive process" 3193: 1429:"A review: Mechanism of action of antiviral drugs" 1340: 789:in weanling mice. It was reported to induce rapid 3697:. Food and Drug Administration. 28 February 2022. 3339:"Emerging influenza antiviral resistance threats" 1975: 1849: 923: 851:One of the best-known of this class of drugs are 9282: 5791:Dolutegravir/emtricitabine/tenofovir alafenamide 3596:"New approaches in the treatment of hepatitis C" 3521: 3472: 3420: 3385: 3241: 3217: 3215: 535:analogues that look like the building blocks of 19:"Antiviral" redirects here. For other uses, see 5849:Emtricitabine/rilpivirine/tenofovir alafenamide 5769:Bictegravir/emtricitabine/tenofovir alafenamide 3425: 3423: 3200:. New York, New York: W. H. Freeman and Company 2976: 1984:Remington, the science and practice of pharmacy 1933:Almela MJ, GonzĂĄlez ME, Carrasco L (May 1991). 1611: 5963: 5854:Emtricitabine/rilpivirine/tenofovir disoproxil 5340:(Integrase strand transfer inhibitors (INSTI)) 2983: 2981: 2979: 2383: 2009:"Activity of Pleconaril against Enteroviruses" 1670: 1475: 7945: 7579: 6846: 6256: 5802:Dolutegravir/lamivudine/tenofovir alafenamide 5196: 4160: 3527: 3336: 3212: 730: 387:of the receptor and anti-receptor antibodies. 5824:Efavirenz/emtricitabine/tenofovir disoproxil 5808:Dolutegravir/lamivudine/tenofovir disoproxil 4175:Major chemical drug groups – based upon the 4064:Centers for Disease Control and Prevention. 3876: 3638: 3587: 3583:. National Health Service, UK. 21 June 2018. 3298:"Viruses are models for embracing diversity" 2987: 2561: 2377: 2336: 2287: 2238: 2189: 2140: 2105: 1883: 1803:"The Pharmacological Potential of Mushrooms" 1723: 1529: 1274: 1229:Discovery and development of NS5A inhibitors 929:immunocompetent patients, hospitalized with 869: 836: 3534:Infectious Disease Clinics of North America 2697: 2602: 2419:AlarcĂłn B, GonzĂĄlez ME, Carrasco L (1988). 2072:"Common Cold Causes: Rhinoviruses and More" 1926: 1469: 1420: 1034:(sofosbuvir, velpatasvir, and voxilaprevir) 983: 7586: 7572: 6853: 6839: 6263: 6249: 5819:Doravirine/lamivudine/tenofovir disoproxil 5203: 5189: 4167: 4153: 4128:Centers for Disease Control and Prevention 4103:Centers for Disease Control and Prevention 4078: 3337:Hayden, FG; de Jong, MD (1 January 2011). 3221: 2890: 1118:Centers for Disease Control and Prevention 887:Centers for Disease Control and Prevention 858:A more specific approach is to synthesize 704:Some viruses include an enzyme known as a 16:Medication used to treat a viral infection 5829:Efavirenz/lamivudine/tenofovir disoproxil 4026: 4024: 4004: 3994: 3945: 3935: 3850: 3848: 3812: 3802: 3769: 3735: 3725: 3670: 3621: 3611: 3553: 3496: 3455: 3403: 3392:The Journal of Antimicrobial Chemotherapy 3386:Kimberlin, DW; Whitley, RJ (March 1996). 3362: 3313: 3273: 3054: 3013: 2847: 2781: 2755: 2732: 2680: 2670: 2585: 2544: 2495: 2436: 2360: 2319: 2262: 2221: 2172: 2096: 2056:Lee, S.; Nguyen, M.; Currier, M. (2016). 2032: 1958: 1889: 1826: 1755: 1706: 1688: 1557: 1503: 1493: 1452: 1376: 1366: 1302: 1292: 514: 413:A very early stage of viral infection is 298:that synthesizes the target protein into 266:Learn how and when to remove this message 6096:Zinc finger protein transcription factor 5926: 3924:Israel Journal of Health Policy Research 3194:Lodish, H; Berk, A; Zipursky, S (2000). 3030: 1015:The DAA combination drugs used include: 893:viruses (H1N1) and (H3N2) and up to two 671: 615: 522: 171: 34: 8660:Ear-Nose-Throat/Upper respiratory tract 7833:Access to water, sanitation and hygiene 3478: 3224:"The error-prone ways of RNA synthesis" 2804: 2647:"Broad-spectrum antiviral therapeutics" 1854:, Springer Singapore, pp. 275–97, 1106: 440: 157:effect were selected for closer study. 9283: 9243:Infectious disease (medical specialty) 9135:Antimicrobial resistance surveillance 5154:Pharmacological classification systems 4521:Selective estrogen receptor modulators 4030: 4021: 3845: 3575: 3573: 2960: 2958: 2956: 2954: 2952: 2950: 2948: 2946: 2568:Odani S, Tominaga K, Kondou S (1999). 2342: 2097:Tang, Roderick; Moore, Martin (2017). 1330:. Cengage Learning, 2011. p. 397. 699: 558:(AZT), is also a nucleoside analogue. 278: 7567: 6834: 6244: 5184: 4801:Non-steroidal anti-inflammatory drugs 4148: 3885:Current Topics in Medicinal Chemistry 3043:Journal of Antimicrobial Chemotherapy 2013:Antimicrobial Agents and Chemotherapy 1666: 1664: 1328:Contemporary Medical-Surgical Nursing 763:Massachusetts Institute of Technology 66:, a larger group which also includes 8490:Compartmental models in epidemiology 4124:"Strategic National Stockpile (SNS)" 1525: 1523: 1147:Public Health Emergency Preparedness 527:One way of doing this is to develop 363: 306:Approaches by virus life cycle stage 204:adding citations to reliable sources 175: 89:. They should be distinguished from 7175:Sofosbuvir/velpatasvir/voxilaprevir 5981: 5844:Emtricitabine/tenofovir alafenamide 4414:Angiotensin II receptor antagonists 3570: 3222:Racaniello, Vincent (10 May 2009). 2943: 967:emergence of antiviral resistance. 164:. Only in the 1980s, when the full 152:, and were found using traditional 78:drugs, or antiviral drugs based on 13: 7290: 5859:Emtricitabine/tenofovir disoproxil 3343:The Journal of Infectious Diseases 2891:Akay S, Karasu Z (November 2008). 2758:"Antiviral Actions of Interferons" 1661: 1532:Recent Advances in Animal Virology 1234:COVID-19 drug repurposing research 1004:(partially indirectly acting) and 683:A ribozyme antiviral to deal with 402: 54:. Most antivirals target specific 14: 9307: 7160:Ombitasvir/paritaprevir/ritonavir 3897:10.2174/1568026621666211012110819 3600:World Journal of Gastroenterology 1520: 957:Detection of antiviral resistance 9239:Economics of Infectious Diseases 6232:. Formerly or rarely used agent. 5869:Lamivudine/nevirapine/zidovudine 5753:Abacavir/dolutegravir/lamivudine 5163: 5143: 5142: 2587:10.1046/j.1432-1327.1999.00463.x 2574:European Journal of Biochemistry 2312:10.1128/JVI.78.11.5891-5899.2004 1172: 1101: 1054:approved DAAs on the basis of a 816: 692:Protein processing and targeting 599: 550:The first successful antiviral, 329:), and sometimes covered with a 180: 6036:Epigallocatechin gallate (EGCG) 5879:Lamivudine/tenofovir disoproxil 5864:Lamivudine/nevirapine/stavudine 4551:Hypothalamic–pituitary hormones 4116: 4091: 4072: 4057: 3962: 3911: 3821: 3778: 3744: 3701: 3687: 3485:New England Journal of Medicine 3379: 3330: 3290: 3162: 3121: 3078: 2884: 2841: 2805:Burra P (2009). "Hepatitis C". 2798: 2749: 2725:10.1128/JVI.68.2.1103-1114.1994 2638: 2512: 2461: 2412: 2214:10.1128/JVI.79.8.5116-5128.2005 2165:10.1128/JVI.79.8.4599-4609.2005 2114:Antisense Nucleic Acid Drug Dev 2090: 2064: 2049: 2000: 1951:10.1128/JVI.65.5.2572-2577.1991 1843: 1794: 1772: 1605: 1294:10.1016/j.antiviral.2014.07.014 1153:. Also managed by the CDC, the 191:needs additional citations for 104: 9248:Infectious disease informatics 9079:Transmission-based precautions 5759:Abacavir/lamivudine/zidovudine 3528:Strasfeld, L; Chou, S (2010). 1619:Journal of Medicinal Chemistry 1566: 1482:Molecules (Basel, Switzerland) 1393: 1334: 1319: 1246: 1135: 1046:(glecaprevir and pibrentasvir) 924:Origin of antiviral resistance 882:, including antiviral agents. 1: 8665:Chest/Lower respiratory tract 8440:Ocular (Eye) mucosal membrane 7801:Behavioral/lifestyle factors 6901:protease inhibitors (–previr) 6589: 4303:Thrombolytics / fibrinolytics 3752:Lawitz, Eric (January 2015). 2988:Pillay, D; Zambon, M (1998). 2774:10.1128/CMR.14.4.778-809.2001 1239: 336:Researchers working on such " 70:(also termed antibacterial), 8227:Aerosol-generating procedure 8005:Silent/Subclinical infection 7705:Multidrug-resistant bacteria 5014:Wakefulness-promoting agents 4079:Hodge, J G; Orenstein, D G. 3996:10.1371/journal.pone.0121952 3791:Clinical Infectious Diseases 3138:10.1007/978-3-540-79086-0_11 2862:10.1097/QCO.0b013e3283184245 2672:10.1371/journal.pone.0022572 2624:10.1016/0006-291X(89)91665-3 2438:10.1016/0014-5793(88)80732-4 2362:10.5483/BMBRep.2003.36.6.538 1860:10.1007/978-981-13-6382-5_10 1748:10.1016/j.drudis.2020.07.008 1631:10.1021/acs.jmedchem.9b00359 1540:10.1007/978-981-13-9073-9_22 1155:Strategic National Stockpile 1142:Strategic National Stockpile 1092:human immunodeficiency virus 1052:Food and Drug Administration 1028:(sofosbuvir and velpatasvir) 813:acts at the assembly phase. 575: 473:, which can cause diarrhea, 321:stored in a capsule made of 39:Antiretroviral drugs for HIV 7: 8891:Vaccine-preventable disease 8839:Monoclonal antibody therapy 5634:Tenofovir alafenamide (TAF) 3651:Annals of Internal Medicine 2990:"Antiviral Drug Resistance" 2478:10.1007/978-3-540-79086-0_4 2386:AIDS Res. Hum. Retroviruses 1165: 1022:(sofosbuvir and ledipasvir) 878:all specific and effective 864:respiratory syncytial virus 805: 500:respiratory syncytial virus 28:Antiviral Therapy (journal) 10: 9312: 9032:Respiratory source control 5629:Tenofovir disoproxil (TDF) 4664:Intravenous immunoglobulin 2909:10.1517/14712598.8.11.1815 2756:Samuel CE (October 2001). 2398:10.1089/088922201750102427 2126:10.1089/108729001753231696 1190:(especially HAART for HIV) 1139: 1040:(elbasvir and grazoprevir) 840: 735:Most viruses produce long 731:Long dsRNA helix targeting 406: 347:Attachment to a host cell. 25: 21:Antiviral (disambiguation) 18: 9222: 9176:Global Health Initiatives 9166:Evolutionary epidemiology 9114: 8906: 8861:Post-exposure prophylaxis 8797:Antimicrobial stewardship 8755: 8742: 8647: 8538: 8520:Multiplicity of infection 8485:Basic reproduction number 8460: 8432: 8418: 8404: 8388: 8356: 8318: 8261:Percutaneous inoculation 8247: 8209: 8202: 8184: 8116: 8083: 8076: 8040: 8033: 7936: 7823: 7745:Host–pathogen interaction 7720: 7614: 7607: 7524: 7489: 7408: 7354: 7326: 7319: 7229: 7205: 7187: 7137: 7055: 6986: 6893: 6884: 6791: 6757: 6734: 6713: 6706: 6630: 6603: 6579: 6548: 6496: 6476: 6392: 6331: 6321: 6312: 6303: 6294: 6189: 6104: 5998: 5980: 5962: 5944: 5925: 5918: 5897: 5738: 5685: 5659: 5650:Discovery and development 5642: 5525: 5513: 5476: 5430: 5421:Discovery and development 5413: 5385: 5335: 5257:Discovery and development 5249: 5231: 5138: 5094: 5066: 5022: 4831: 4766: 4729: 4677: 4590: 4534: 4494: 4451: 4335: 4271: 4183: 3937:10.1186/s13584-015-0028-5 3727:10.1186/s12879-015-0748-8 3546:10.1016/j.idc.2010.01.001 3315:10.1038/s41564-018-0145-3 1690:10.3390/molecules27030850 1591:10.1016/j.rmu.2015.05.003 1495:10.3390/molecules26040810 1445:10.1177/20587384211002621 870:Antiviral drug resistance 837:Immune system stimulation 8994:Protective sequestration 8856:Pre-exposure prophylaxis 8147:Generational difference 7700:Horizontal gene transfer 7690:Antimicrobial resistance 7287:neuraminidase inhibitors 7150:Glecaprevir/pibrentasvir 5946:Transcription inhibitors 5898:Pharmacokinetic boosters 5814:Dolutegravir/rilpivirine 5775:Cabotegravir/rilpivirine 5415:Protease Inhibitors (PI) 4719:Topoisomerase inhibitors 4403:renin–angiotensin system 4397:Calcium channel blockers 4038:(Report). Archived from 4031:NACCHO (December 2010). 3006:10.1136/bmj.317.7159.660 2899:(Submitted manuscript). 2537:10.1177/0192623308327119 2060:. Nature Communications. 1114:local health departments 1065:hepatocellular carcinoma 990:Direct-acting antivirals 984:Direct-acting antivirals 60:broad-spectrum antiviral 9181:Microbial phylogenetics 9099:Wastewater surveillance 8620:Geographic distribution 8495:Critical community size 8293:Surgical site infection 8141:Iatrogenic/Medical care 8060:Microbial translocation 8056:Endogenous reactivation 8051:Normal flora overgrowth 8000:Opportunistic infection 7772:Opportunistic infection 6714:Nucleic acid inhibitors 6230:initial regimen options 5796:Dolutegravir/lamivudine 5273:Enfuvirtide (ENF, T-20) 5251:Entry/fusion inhibitors 3714:BMC Infectious Diseases 3613:10.3748/wjg.v22.i4.1421 2850:Curr. Opin. Infect. Dis 2343:Ryu KJ, Lee SW (2003). 2264:10.1053/jhep.2003.50330 1368:10.1073/pnas.0832472100 1210:List of antiviral drugs 769:, Amapari and Tacaribe 9253:Microbial bioterrorism 8876:efficacy/effectiveness 8284:Surgical intervention 8176:Breakthrough infection 7798:Genetic predisposition 7782:Susceptible individual 7629:Germ theory of disease 7490:Multiple/Unknown/Other 7259:adamantane derivatives 7170:Sofosbuvir/velpatasvir 7165:Sofosbuvir/daclatasvir 6071:Portmanteau inhibitors 5964:Translation inhibitors 5874:Lamivudine/raltegravir 5644:Non-nucleoside (NNRTI) 5602:Islatravir (EFdA, ISL) 4511:Hormonal contraception 4441:Bile acid sequestrants 4222:Proton-pump inhibitors 4185:gastrointestinal tract 3581:"Overview-Hepatitis C" 3266:10.1098/rspb.2009.1247 2819:10.1055/s-0029-1192055 1579:Medicina Universitaria 747:during transcription. 515:During viral synthesis 40: 9089:Universal precautions 8047:Endogenous overgrowth 7899:Poultry and livestock 7358:inhibitors (–trelvir) 7346:Peginterferon alfa-2b 7341:Peginterferon alfa-2a 7155:Ledipasvir/sofosbuvir 6749:Peginterferon alfa-2a 6698:Tenofovir alafenamide 6086:Synergistic enhancers 5884:Lamivudine/zidovudine 5764:Atazanavir/cobicistat 5740:Combined formulations 5577:Zidovudine (AZT, ZDV) 5515:Reverse-transcriptase 5387:Maturation inhibitors 3355:10.1093/infdis/jiq012 2897:Expert Opin Biol Ther 2349:J. Biochem. Mol. Biol 2025:10.1128/AAC.43.9.2109 1439:: 20587384211002621. 1275:Rossignol JF (2014). 672:Translation/ribozymes 616:Translation/antisense 610:transcription factors 545:reverse transcriptase 523:Reverse transcription 492:Nature Communications 289:computer-aided design 172:Antiviral drug design 80:monoclonal antibodies 38: 9191:Genomic reassortment 9171:Genetic epidemiology 9010:Health communication 8938:Flattening the curve 8928:Disease surveillance 8711:Systemic/Generalized 8475:Animal disease model 7955:Asymptomatic carrier 7145:Elbasvir/grazoprevir 6693:Tenofovir disoproxil 6679:Nucleotide analogues 6642:Nucleoside analogues 5927:Uncoating inhibitors 5780:Darunavir/cobicistat 5620:Nucleotide analogues 5538:Nucleoside analogues 5337:Integrase inhibitors 5216:antiretroviral drugs 5120:Radiopharmaceuticals 4908:Antiparkinson agents 3498:10.1056/NEJMp0900648 3405:10.1093/jac/37.3.403 3180:on 1 September 2014. 3130:Antiviral Strategies 3087:Nature Biotechnology 2762:Clin. Microbiol. Rev 2470:Antiviral Strategies 1736:Drug Discovery Today 1534:. pp. 425–446. 1159:Antiviral stockpiles 1107:Use and distribution 1076:herpes simplex virus 916:Nature Biotechnology 875:Antiviral resistance 441:Uncoating inhibitors 383:antibodies, natural 338:rational drug design 317:and sometimes a few 200:improve this article 99:Australian tea trees 9258:Pandemic prevention 9214:Viral phylodynamics 9195:Re-emerging disease 9084:Travel restrictions 8288:Postoperative wound 8257:Blood-borne disease 8239:Respiratory droplet 8151:Vertical/Congenital 8136:Nosocomial/Hospital 8093:Spillover infection 7062:inhibitors (–buvir) 6990:inhibitors (–asvir) 6394:Pyrimidine analogue 5919:Experimental agents 5889:Lopinavir/ritonavir 5748:Abacavir/lamivudine 5722:Elsulfavirine (ESV) 5557:Emtricitabine (FTC) 5443:Fosamprenavir (FPV) 4903:Antimigraine agents 4893:Antidementia agents 4796:Anti-inflammatories 4486:Medicated dressings 4426:Antihyperlipidemics 4253:Diabetes medication 3987:2015PLoSO..1021952L 3479:Moscona, A (2009). 3302:Nature Microbiology 3099:10.1038/nbt0609-510 2663:2011PLoSO...622572R 2153:Journal of Virology 1819:10.1093/ecam/neh107 1359:2003PNAS..100.8013K 1205:Monoclonal antibody 1188:Antiretroviral drug 755:double-stranded RNA 710:protease inhibitors 700:Protease inhibitors 504:parainfluenza virus 279:Antiviral targeting 9204:Selection pressure 8500:Force of infection 8128:Contagious disease 8063:Endogenous seeding 7960:Chain of infection 7884:Injection drug use 7795:Vaccination status 7678:Case fatality rate 7596:infectious disease 7551:Never to phase III 7409:RNA pol inhibitors 7336:Interferon alfa 2b 7241:Baloxavir marboxil 6818:Never to phase III 6744:Interferon alfa 2b 6216:Never to phase III 5362:Elvitegravir (EVG) 5357:Dolutegravir (DTG) 5352:Cabotegravir (CAB) 4756:Immunosuppressants 4626:Antimycobacterials 4582:Antithyroid agents 4566:Mineralocorticoids 4370:Cardiac stimulants 4360:Cardiac glycosides 4352:cardiac therapy / 4248:Anti-obesity drugs 4045:on 22 October 2016 3804:10.1093/cid/civ396 3056:10.1093/jac/dkq100 2972:. 25 October 2018. 1151:pandemic influenza 1056:surrogate endpoint 1050:The United States 943:quasispecies model 757:activated caspase 580:Another target is 465:, which cause the 296:inserting the gene 50:used for treating 41: 9278: 9277: 9268:Tropical medicine 9209:Synthetic biology 9110: 9109: 9069:Social distancing 9022:Outbreak response 8643: 8642: 8470:Agent-based model 8456: 8455: 8452: 8451: 8448: 8447: 7995:Natural reservoir 7985:Infectious period 7975:Incubation period 7932: 7931: 7888:Natural disaster 7857:Tropical diseases 7840:Biodiversity loss 7777:Risk of infection 7767:Microbiome health 7760:Immunosuppression 7561: 7560: 7520: 7519: 7183: 7182: 7138:Combination drugs 6828: 6827: 6787: 6786: 6626: 6625: 6544: 6543: 6492: 6491: 6472: 6471: 6238: 6237: 6185: 6184: 6031:Diarylpyrimidines 5734: 5733: 5730: 5729: 5710:Rilpivirine (RPV) 5694:diarylpyrimidines 5677:Delavirdine (DLV) 5572:Zalcitabine (ddC) 5529:nucleotide (NRTI) 5509: 5508: 5367:Raltegravir (RAL) 5347:Bictegravir (BIC) 5326:Fostemsavir (FTR) 5241:Lenacapavir (LEN) 5233:Capsid inhibitors 5178: 5177: 5081:Ophthalmologicals 4791:Anabolic steroids 4694:Anticancer agents 4657:Ectoparasiticides 4377:Antihypertensives 4325:Antifibrinolytics 3891:(30): 2687–2693. 3870:10.1002/hep.29408 3771:10.1002/hep.27366 3448:10.1093/ve/vew014 3147:978-3-540-79085-3 2931:on 3 October 2021 2487:978-3-540-79085-3 2078:on 8 January 2022 1993:978-0-7817-4673-1 1904:10.1159/000024948 1869:978-981-13-6382-5 1625:(21): 9375–9414. 1549:978-981-13-9072-2 1122:2009 flu pandemic 1120:(CDC) during the 767:dengue flavivirus 364:Before cell entry 276: 275: 268: 250: 166:genetic sequences 9303: 9263:Tropical disease 9199:Reverse zoonosis 9186:One Health Model 9015:Health education 9004:Community health 8923:Cordon sanitaire 8896:Ring vaccination 8866:Repurposed drugs 8753: 8752: 8672:Gastrointestinal 8515:Machine learning 8319:Gastrointestinal 8270:Intravenous line 8207: 8206: 8121:/Cross-infection 8108:Reverse zoonosis 8081: 8080: 8038: 8037: 7943: 7942: 7924:War and conflict 7792:Nutrition status 7755:Immunodeficiency 7612: 7611: 7588: 7581: 7574: 7565: 7564: 7324: 7323: 7320:Multiple/general 6891: 6890: 6855: 6848: 6841: 6832: 6831: 6758:Multiple/unknown 6711: 6710: 6707:Multiple/general 6477:Not TK activated 6329: 6328: 6319: 6318: 6310: 6309: 6301: 6300: 6265: 6258: 6251: 6242: 6241: 6056:Hydroxycarbamide 5923: 5922: 5717:Doravirine (DOR) 5705:Etravirine (ETR) 5700:Dapivirine (DPV) 5672:Nevirapine (NVP) 5657: 5656: 5562:Lamivudine (3TC) 5552:Didanosine (ddI) 5523: 5522: 5496:Tipranavir (TPV) 5484:Atazanavir (ATV) 5468:Saquinavir (SQV) 5458:Nelfinavir (NFV) 5438:Amprenavir (APV) 5428: 5427: 5310:Ibalizumab (IBA) 5205: 5198: 5191: 5182: 5181: 5167: 5146: 5145: 5130:Senotherapeutics 4984:Neuroprotectives 4979:Mood stabilizers 4878:Anti-ADHD agents 4818:Muscle relaxants 4751:Immunostimulants 4746:Immunomodulators 4578:Thyroid hormones 4516:Fertility agents 4419:Renin inhibitors 4310:Antihemorrhagics 4277:forming organs ( 4263:Dietary minerals 4169: 4162: 4155: 4146: 4145: 4139: 4138: 4136: 4134: 4120: 4114: 4113: 4111: 4109: 4095: 4089: 4088: 4076: 4070: 4069: 4061: 4055: 4054: 4052: 4050: 4044: 4037: 4028: 4019: 4018: 4008: 3998: 3966: 3960: 3959: 3949: 3939: 3915: 3909: 3908: 3880: 3874: 3873: 3852: 3843: 3842: 3841:(24): 2584–2593. 3829:December 2012). 3825: 3819: 3818: 3816: 3806: 3782: 3776: 3775: 3773: 3748: 3742: 3741: 3739: 3729: 3705: 3699: 3698: 3691: 3685: 3684: 3674: 3663:10.7326/M16-2575 3642: 3636: 3635: 3625: 3615: 3591: 3585: 3584: 3577: 3568: 3567: 3557: 3525: 3519: 3518: 3500: 3476: 3470: 3469: 3459: 3427: 3418: 3417: 3407: 3383: 3377: 3376: 3366: 3334: 3328: 3327: 3317: 3308:(4): 389. 2018. 3294: 3288: 3287: 3277: 3260:(1682): 809–17. 3245: 3239: 3238: 3236: 3234: 3219: 3210: 3209: 3207: 3205: 3191: 3182: 3181: 3176:. Archived from 3166: 3160: 3159: 3125: 3119: 3118: 3082: 3076: 3075: 3073: 3071: 3058: 3034: 3028: 3027: 3017: 3000:(7159): 660–62. 2985: 2974: 2973: 2962: 2941: 2940: 2938: 2936: 2927:. Archived from 2888: 2882: 2881: 2845: 2839: 2838: 2807:Semin. Liver Dis 2802: 2796: 2795: 2785: 2753: 2747: 2746: 2736: 2701: 2695: 2694: 2684: 2674: 2642: 2636: 2635: 2606: 2600: 2599: 2589: 2565: 2559: 2558: 2548: 2516: 2510: 2509: 2499: 2465: 2459: 2458: 2440: 2416: 2410: 2409: 2381: 2375: 2374: 2364: 2340: 2334: 2333: 2323: 2291: 2285: 2284: 2266: 2242: 2236: 2235: 2225: 2193: 2187: 2186: 2176: 2159:(8): 4599–4609. 2144: 2138: 2137: 2109: 2103: 2102: 2094: 2088: 2087: 2085: 2083: 2074:. Archived from 2068: 2062: 2061: 2053: 2047: 2046: 2036: 2019:(9): 2109–2115. 2004: 1998: 1997: 1979: 1973: 1972: 1962: 1930: 1924: 1923: 1887: 1881: 1880: 1847: 1841: 1840: 1830: 1798: 1792: 1791: 1789: 1787: 1776: 1770: 1769: 1759: 1742:(9): 1604–1613. 1727: 1721: 1720: 1710: 1692: 1668: 1659: 1658: 1609: 1603: 1602: 1570: 1564: 1563: 1561: 1527: 1518: 1517: 1507: 1497: 1473: 1467: 1466: 1456: 1424: 1418: 1417: 1397: 1391: 1390: 1380: 1370: 1338: 1332: 1331: 1323: 1317: 1316: 1306: 1296: 1272: 1266: 1265: 1254:Antiviral Agents 1250: 1182: 1177: 1176: 1130:chemoprophylaxis 1112:Furthermore, in 271: 264: 260: 257: 251: 249: 215:"Antiviral drug" 208: 184: 176: 52:viral infections 9311: 9310: 9306: 9305: 9304: 9302: 9301: 9300: 9291:Antiviral drugs 9281: 9280: 9279: 9274: 9218: 9131:Antigenic shift 9126:Antigenic drift 9117: 9106: 8970:Barrier nursing 8918:Contact tracing 8909: 8902: 8747: 8745: 8738: 8649: 8639: 8540: 8534: 8525:Serial interval 8444: 8428: 8419:Cervico-vaginal 8414: 8405:Trans-placental 8400: 8384: 8352: 8314: 8250:Vascular system 8249: 8243: 8198: 8186: 8180: 8120: 8112: 8072: 8029: 7947: 7928: 7819: 7750:Immune response 7716: 7695:Drug resistance 7639:Infectious dose 7603: 7592: 7562: 7557: 7556: 7541:Clinical trials 7516: 7485: 7404: 7350: 7315: 7225: 7201: 7179: 7133: 7051: 6982: 6880: 6859: 6829: 6824: 6823: 6808:Clinical trials 6783: 6753: 6730: 6702: 6622: 6599: 6575: 6571:Podophyllotoxin 6540: 6488: 6468: 6388: 6333:Purine analogue 6314: 6290: 6269: 6239: 6234: 6233: 6221: 6206:Clinical trials 6181: 6132:Dexelvucitabine 6100: 6091:Tre recombinase 5994: 5976: 5958: 5954:Tat antagonists 5940: 5914: 5893: 5726: 5681: 5667:Efavirenz (EFV) 5646: 5638: 5567:Stavudine (d4T) 5528: 5516: 5505: 5490:Darunavir (DRV) 5472: 5463:Ritonavir (RTV) 5453:Lopinavir (LPV) 5448:Indinavir (IDV) 5417: 5409: 5381: 5339: 5331: 5285:Maraviroc (MVC) 5253: 5245: 5227: 5212:Antiviral drugs 5209: 5179: 5174: 5170:Medicine portal 5134: 5090: 5062: 5057: 5049:Cough medicines 5044:Bronchodilators 5025: 5018: 4898:Antidepressants 4888:Anticonvulsants 4836: 4827: 4823:Bisphosphonates 4813:Corticosteroids 4775: 4762: 4734: 4725: 4709:Spindle poisons 4699:Antimetabolites 4682: 4673: 4595: 4586: 4561:Glucocorticoids 4556:Corticosteroids 4537: 4530: 4497: 4490: 4447: 4365:Antiarrhythmics 4338: 4331: 4288:Antithrombotics 4276: 4267: 4243:Antipropulsives 4239:Antidiarrhoeals 4216: 4187: 4179: 4173: 4143: 4142: 4132: 4130: 4122: 4121: 4117: 4107: 4105: 4097: 4096: 4092: 4077: 4073: 4062: 4058: 4048: 4046: 4042: 4035: 4029: 4022: 3981:(3): e0121952. 3967: 3963: 3916: 3912: 3881: 3877: 3853: 3846: 3826: 3822: 3783: 3779: 3749: 3745: 3706: 3702: 3693: 3692: 3688: 3643: 3639: 3592: 3588: 3579: 3578: 3571: 3526: 3522: 3477: 3473: 3436:Virus Evolution 3428: 3421: 3384: 3380: 3335: 3331: 3296: 3295: 3291: 3254:Proc. Biol. Sci 3246: 3242: 3232: 3230: 3220: 3213: 3203: 3201: 3192: 3185: 3168: 3167: 3163: 3148: 3126: 3122: 3083: 3079: 3069: 3067: 3035: 3031: 2986: 2977: 2964: 2963: 2944: 2934: 2932: 2903:(11): 1815–22. 2889: 2885: 2846: 2842: 2803: 2799: 2754: 2750: 2702: 2698: 2643: 2639: 2607: 2603: 2566: 2562: 2517: 2513: 2488: 2466: 2462: 2417: 2413: 2382: 2378: 2341: 2337: 2306:(11): 5891–99. 2292: 2288: 2243: 2239: 2194: 2190: 2145: 2141: 2110: 2106: 2095: 2091: 2081: 2079: 2070: 2069: 2065: 2054: 2050: 2005: 2001: 1994: 1980: 1976: 1931: 1927: 1888: 1884: 1870: 1848: 1844: 1799: 1795: 1785: 1783: 1778: 1777: 1773: 1728: 1724: 1669: 1662: 1610: 1606: 1585:(68): 165–174. 1571: 1567: 1550: 1528: 1521: 1474: 1470: 1425: 1421: 1398: 1394: 1353:(13): 8013–18. 1339: 1335: 1324: 1320: 1273: 1269: 1252: 1251: 1247: 1242: 1220:Antiprion drugs 1178: 1171: 1168: 1144: 1138: 1109: 1104: 1096:interferon alfa 1084:cytomegalovirus 994:antiviral drugs 986: 973: 959: 926: 909:(Relenza), and 872: 845: 843:immunostimulant 839: 819: 808: 733: 721:Lentinus edodes 702: 694: 674: 650:West Nile virus 627:cytomegalovirus 618: 602: 578: 525: 517: 443: 411: 409:Entry inhibitor 405: 403:Entry inhibitor 366: 308: 281: 272: 261: 255: 252: 209: 207: 197: 185: 174: 154:trial-and-error 107: 46:are a class of 44:Antiviral drugs 31: 24: 17: 12: 11: 5: 9309: 9299: 9298: 9293: 9276: 9275: 9273: 9272: 9271: 9270: 9260: 9255: 9250: 9245: 9240: 9237: 9232: 9226: 9224: 9220: 9219: 9217: 9216: 9211: 9206: 9201: 9196: 9193: 9188: 9183: 9178: 9173: 9168: 9163: 9161:Emergent virus 9158: 9153: 9148: 9143: 9142: 9141: 9133: 9128: 9122: 9120: 9112: 9111: 9108: 9107: 9105: 9104: 9101: 9096: 9094:Vector control 9091: 9086: 9081: 9076: 9071: 9066: 9061: 9056: 9051: 9050: 9049: 9044: 9039: 9037:N95 respirator 9029: 9024: 9019: 9018: 9017: 9012: 9007: 8996: 8991: 8990: 8989: 8979: 8974: 8973: 8972: 8962: 8961: 8960: 8955: 8950: 8940: 8935: 8930: 8925: 8920: 8914: 8912: 8910:pharmaceutical 8904: 8903: 8901: 8900: 8899: 8898: 8893: 8888: 8883: 8878: 8868: 8863: 8858: 8853: 8848: 8843: 8842: 8841: 8831: 8826: 8821: 8816: 8811: 8806: 8801: 8800: 8799: 8789: 8788: 8787: 8777: 8772: 8771: 8770: 8759: 8757: 8756:Pharmaceutical 8750: 8740: 8739: 8737: 8736: 8733: 8728: 8723: 8718: 8713: 8708: 8707:Cardiovascular 8705: 8700: 8695: 8692: 8687: 8686:Nervous system 8684: 8681: 8680: 8679: 8669: 8668: 8667: 8662: 8653: 8651: 8645: 8644: 8641: 8640: 8638: 8637: 8632: 8627: 8622: 8617: 8612: 8607: 8602: 8597: 8592: 8587: 8582: 8577: 8572: 8571: 8570: 8565: 8555: 8550: 8544: 8542: 8536: 8535: 8533: 8532: 8527: 8522: 8517: 8512: 8510:Infection rate 8507: 8502: 8497: 8492: 8487: 8482: 8477: 8472: 8466: 8464: 8458: 8457: 8454: 8453: 8450: 8449: 8446: 8445: 8443: 8442: 8436: 8434: 8430: 8429: 8427: 8426: 8422: 8420: 8416: 8415: 8413: 8412: 8408: 8406: 8402: 8401: 8399: 8398: 8392: 8390: 8386: 8385: 8383: 8382: 8376: 8371: 8366: 8360: 8358: 8354: 8353: 8351: 8350: 8345: 8340: 8335: 8334: 8333: 8322: 8320: 8316: 8315: 8313: 8312: 8311: 8310: 8305: 8297: 8296: 8295: 8290: 8282: 8281: 8280: 8275: 8272: 8267: 8265:Injection site 8259: 8253: 8251: 8245: 8244: 8242: 8241: 8236: 8234:Dental aerosol 8231: 8230: 8229: 8219: 8213: 8211: 8204: 8200: 8199: 8197: 8196: 8190: 8188: 8182: 8181: 8179: 8178: 8173: 8172: 8171: 8166: 8165: 8164: 8159: 8156: 8145: 8144: 8143: 8138: 8130: 8124: 8122: 8118:Human-to-human 8114: 8113: 8111: 8110: 8105: 8100: 8095: 8089: 8087: 8078: 8074: 8073: 8071: 8070: 8064: 8061: 8058: 8053: 8048: 8044: 8042: 8035: 8031: 8030: 8028: 8027: 8022: 8017: 8015:Super-spreader 8012: 8010:Superinfection 8007: 8002: 7997: 7992: 7987: 7982: 7977: 7972: 7967: 7962: 7957: 7951: 7949: 7940: 7934: 7933: 7930: 7929: 7927: 7926: 7921: 7919:Vector control 7916: 7911: 7906: 7901: 7896: 7895: 7894: 7886: 7881: 7876: 7871: 7866: 7861: 7860: 7859: 7854: 7848:Climate zones 7846: 7844:Climate change 7841: 7838: 7835: 7829: 7827: 7821: 7820: 7818: 7817: 7816: 7815: 7812: 7809: 7808: 7807: 7799: 7796: 7793: 7790: 7787: 7779: 7774: 7769: 7764: 7763: 7762: 7757: 7747: 7742: 7737: 7732: 7726: 7724: 7718: 7717: 7715: 7714: 7709: 7708: 7707: 7702: 7697: 7687: 7686: 7685: 7680: 7675: 7670: 7660: 7658:Quorum sensing 7655: 7654: 7653: 7643: 7642: 7641: 7631: 7626: 7620: 7618: 7609: 7605: 7604: 7591: 7590: 7583: 7576: 7568: 7559: 7558: 7555: 7554: 7553: 7552: 7549: 7538: 7532: 7526: 7525: 7522: 7521: 7518: 7517: 7515: 7514: 7509: 7504: 7499: 7493: 7491: 7487: 7486: 7484: 7483: 7481:Valopicitabine 7478: 7473: 7468: 7463: 7458: 7453: 7448: 7443: 7438: 7433: 7428: 7423: 7418: 7412: 7410: 7406: 7405: 7403: 7402: 7392: 7387: 7377: 7372: 7367: 7361: 7359: 7352: 7351: 7349: 7348: 7343: 7338: 7332: 7330: 7321: 7317: 7316: 7314: 7313: 7303: 7298: 7282: 7281: 7275: 7270: 7254: 7253: 7248: 7243: 7237: 7235: 7227: 7226: 7224: 7223: 7211: 7209: 7203: 7202: 7200: 7199: 7193: 7191: 7185: 7184: 7181: 7180: 7178: 7177: 7172: 7167: 7162: 7157: 7152: 7147: 7141: 7139: 7135: 7134: 7132: 7131: 7126: 7121: 7116: 7111: 7106: 7101: 7096: 7091: 7086: 7081: 7076: 7071: 7065: 7063: 7060:RNA polymerase 7053: 7052: 7050: 7049: 7044: 7039: 7034: 7029: 7024: 7019: 7014: 7009: 7004: 6999: 6993: 6991: 6984: 6983: 6981: 6980: 6975: 6970: 6965: 6960: 6955: 6950: 6945: 6940: 6935: 6930: 6925: 6920: 6915: 6910: 6904: 6902: 6888: 6882: 6881: 6858: 6857: 6850: 6843: 6835: 6826: 6825: 6822: 6821: 6820: 6819: 6816: 6805: 6799: 6793: 6792: 6789: 6788: 6785: 6784: 6782: 6781: 6776: 6767: 6761: 6759: 6755: 6754: 6752: 6751: 6746: 6740: 6738: 6732: 6731: 6729: 6728: 6723: 6717: 6715: 6708: 6704: 6703: 6701: 6700: 6695: 6690: 6674: 6673: 6668: 6663: 6658: 6653: 6637: 6635: 6628: 6627: 6624: 6623: 6621: 6620: 6615: 6609: 6607: 6601: 6600: 6598: 6597: 6585: 6583: 6577: 6576: 6574: 6573: 6568: 6558: 6556: 6546: 6545: 6542: 6541: 6539: 6538: 6533: 6521: 6516: 6511: 6506: 6500: 6498: 6494: 6493: 6490: 6489: 6487: 6486: 6480: 6478: 6474: 6473: 6470: 6469: 6467: 6466: 6453: 6452: 6451: 6450: 6445: 6440: 6427: 6426: 6420: 6410: 6398: 6396: 6390: 6389: 6387: 6386: 6373: 6372: 6362: 6360:Valganciclovir 6353: 6337: 6335: 6326: 6316: 6307: 6298: 6292: 6291: 6268: 6267: 6260: 6253: 6245: 6236: 6235: 6220: 6219: 6218: 6217: 6214: 6203: 6197: 6191: 6190: 6187: 6186: 6183: 6182: 6180: 6179: 6174: 6169: 6164: 6159: 6154: 6149: 6144: 6139: 6134: 6129: 6124: 6119: 6114: 6108: 6106: 6102: 6101: 6099: 6098: 6093: 6088: 6083: 6078: 6073: 6068: 6063: 6058: 6053: 6048: 6043: 6038: 6033: 6028: 6023: 6018: 6013: 6008: 6002: 6000: 5996: 5995: 5993: 5992: 5986: 5984: 5978: 5977: 5975: 5974: 5968: 5966: 5960: 5959: 5957: 5956: 5950: 5948: 5942: 5941: 5939: 5938: 5931: 5929: 5920: 5916: 5915: 5913: 5912: 5907: 5905:Cobicistat (c) 5901: 5899: 5895: 5894: 5892: 5891: 5886: 5881: 5876: 5871: 5866: 5861: 5856: 5851: 5846: 5841: 5836: 5831: 5826: 5821: 5816: 5811: 5805: 5799: 5793: 5788: 5782: 5777: 5772: 5766: 5761: 5756: 5750: 5744: 5742: 5736: 5735: 5732: 5731: 5728: 5727: 5725: 5724: 5719: 5714: 5713: 5712: 5707: 5702: 5689: 5687: 5683: 5682: 5680: 5679: 5674: 5669: 5663: 5661: 5654: 5640: 5639: 5637: 5636: 5631: 5615: 5614: 5609: 5604: 5599: 5594: 5589: 5584: 5579: 5574: 5569: 5564: 5559: 5554: 5549: 5547:Abacavir (ABC) 5533: 5531: 5527:Nucleoside and 5520: 5511: 5510: 5507: 5506: 5504: 5503: 5498: 5493: 5487: 5480: 5478: 5474: 5473: 5471: 5470: 5465: 5460: 5455: 5450: 5445: 5440: 5434: 5432: 5425: 5411: 5410: 5408: 5407: 5402: 5397: 5391: 5389: 5383: 5382: 5380: 5379: 5374: 5369: 5364: 5359: 5354: 5349: 5343: 5341: 5333: 5332: 5330: 5329: 5317: 5301: 5287: 5276: 5263: 5261: 5247: 5246: 5244: 5243: 5237: 5235: 5229: 5228: 5208: 5207: 5200: 5193: 5185: 5176: 5175: 5173: 5172: 5161: 5156: 5151: 5139: 5136: 5135: 5133: 5132: 5127: 5122: 5117: 5115:Contrast media 5112: 5106: 5104: 5092: 5091: 5089: 5088: 5083: 5077: 5075: 5068:sensory organs 5064: 5063: 5061: 5060: 5055: 5051: 5046: 5041: 5035: 5033: 5020: 5019: 5017: 5016: 5011: 5006: 5001: 4996: 4991: 4986: 4981: 4976: 4967: 4966: 4965: 4960: 4955: 4945: 4940: 4935: 4930: 4925: 4920: 4915: 4913:Antipsychotics 4910: 4905: 4900: 4895: 4890: 4885: 4883:Antiaddictives 4880: 4875: 4870: 4869: 4868: 4863: 4853: 4847: 4845: 4838:nervous system 4829: 4828: 4826: 4825: 4820: 4815: 4810: 4808:Antirheumatics 4805: 4804: 4803: 4793: 4787: 4785: 4764: 4763: 4761: 4760: 4759: 4758: 4753: 4742: 4740: 4727: 4726: 4724: 4723: 4722: 4721: 4716: 4714:Antineoplastic 4711: 4706: 4701: 4690: 4688: 4675: 4674: 4672: 4671: 4666: 4661: 4660: 4659: 4654: 4649: 4647:Antiprotozoals 4642:Antiparasitics 4639: 4634: 4629: 4622:Antibacterials 4618:Antimicrobials 4614: 4612: 4588: 4587: 4585: 4584: 4575: 4570: 4569: 4568: 4563: 4553: 4547: 4545: 4532: 4531: 4529: 4528: 4523: 4518: 4513: 4507: 4505: 4492: 4491: 4489: 4488: 4483: 4481:Antipsoriatics 4478: 4473: 4468: 4462: 4460: 4449: 4448: 4446: 4445: 4444: 4443: 4438: 4433: 4423: 4422: 4421: 4416: 4411: 4409:ACE inhibitors 4399: 4394: 4389: 4384: 4379: 4374: 4373: 4372: 4367: 4362: 4348: 4346: 4337:cardiovascular 4333: 4332: 4330: 4329: 4328: 4327: 4322: 4317: 4307: 4306: 4305: 4300: 4298:Anticoagulants 4295: 4284: 4282: 4269: 4268: 4266: 4265: 4260: 4255: 4250: 4245: 4236: 4231: 4226: 4225: 4224: 4219: 4214: 4210: 4199: 4197: 4181: 4180: 4172: 4171: 4164: 4157: 4149: 4141: 4140: 4115: 4090: 4071: 4056: 4020: 3961: 3910: 3875: 3864:(2): 487–497. 3844: 3820: 3797:(5): 730–740. 3777: 3743: 3700: 3686: 3657:(9): 637–648. 3637: 3606:(4): 1421–32. 3586: 3569: 3520: 3491:(10): 953–56. 3471: 3419: 3378: 3329: 3289: 3240: 3211: 3183: 3161: 3146: 3120: 3077: 3049:(6): 1086–93. 3029: 2975: 2942: 2883: 2840: 2797: 2768:(4): 778–809. 2748: 2719:(2): 1103–14. 2696: 2637: 2601: 2560: 2525:Toxicol Pathol 2511: 2486: 2460: 2411: 2376: 2335: 2286: 2237: 2208:(8): 5116–28. 2188: 2139: 2104: 2089: 2063: 2048: 1999: 1992: 1974: 1945:(5): 2572–77. 1925: 1882: 1868: 1842: 1793: 1771: 1722: 1660: 1604: 1565: 1548: 1519: 1468: 1419: 1392: 1333: 1318: 1267: 1244: 1243: 1241: 1238: 1237: 1236: 1231: 1226: 1217: 1212: 1207: 1202: 1196: 1191: 1184: 1183: 1180:Viruses portal 1167: 1164: 1140:Main article: 1137: 1134: 1124:caused by the 1108: 1105: 1103: 1100: 1048: 1047: 1041: 1035: 1029: 1023: 996:used to treat 985: 982: 972: 969: 958: 955: 925: 922: 880:antimicrobials 871: 868: 841:Main article: 838: 835: 825:(Relenza) and 818: 815: 807: 804: 779:H1N1 influenza 732: 729: 701: 698: 693: 690: 673: 670: 669: 668: 663: 658: 653: 643: 617: 614: 601: 598: 577: 574: 524: 521: 516: 513: 479:conjunctivitis 461:works against 442: 439: 407:Main article: 404: 401: 396: 395: 388: 381:anti-idiotypic 365: 362: 361: 360: 357: 354: 351: 348: 307: 304: 280: 277: 274: 273: 256:September 2022 188: 186: 179: 173: 170: 150:herpes viruses 115:herpes viruses 106: 103: 64:antimicrobials 15: 9: 6: 4: 3: 2: 9308: 9297: 9294: 9292: 9289: 9288: 9286: 9269: 9266: 9265: 9264: 9261: 9259: 9256: 9254: 9251: 9249: 9246: 9244: 9241: 9238: 9236: 9233: 9231: 9228: 9227: 9225: 9221: 9215: 9212: 9210: 9207: 9205: 9202: 9200: 9197: 9194: 9192: 9189: 9187: 9184: 9182: 9179: 9177: 9174: 9172: 9169: 9167: 9164: 9162: 9159: 9157: 9154: 9152: 9149: 9147: 9144: 9140: 9137: 9136: 9134: 9132: 9129: 9127: 9124: 9123: 9121: 9119: 9113: 9102: 9100: 9097: 9095: 9092: 9090: 9087: 9085: 9082: 9080: 9077: 9075: 9074:Sterilization 9072: 9070: 9067: 9065: 9062: 9060: 9057: 9055: 9052: 9048: 9045: 9043: 9042:Surgical mask 9040: 9038: 9035: 9034: 9033: 9030: 9028: 9025: 9023: 9020: 9016: 9013: 9011: 9008: 9005: 9002: 9001: 9000: 8999:Public health 8997: 8995: 8992: 8988: 8985: 8984: 8983: 8980: 8978: 8975: 8971: 8968: 8967: 8966: 8963: 8959: 8956: 8954: 8951: 8949: 8946: 8945: 8944: 8941: 8939: 8936: 8934: 8931: 8929: 8926: 8924: 8921: 8919: 8916: 8915: 8913: 8911: 8905: 8897: 8894: 8892: 8889: 8887: 8884: 8882: 8879: 8877: 8874: 8873: 8872: 8869: 8867: 8864: 8862: 8859: 8857: 8854: 8852: 8851:Phage therapy 8849: 8847: 8844: 8840: 8837: 8836: 8835: 8834:Immunotherapy 8832: 8830: 8827: 8825: 8822: 8820: 8817: 8815: 8812: 8810: 8807: 8805: 8802: 8798: 8795: 8794: 8793: 8792:Antimicrobial 8790: 8786: 8783: 8782: 8781: 8778: 8776: 8773: 8769: 8766: 8765: 8764: 8761: 8760: 8758: 8754: 8751: 8749: 8741: 8734: 8732: 8729: 8727: 8724: 8722: 8719: 8717: 8714: 8712: 8709: 8706: 8704: 8701: 8699: 8696: 8693: 8691: 8688: 8685: 8683:Genitourinary 8682: 8678: 8675: 8674: 8673: 8670: 8666: 8663: 8661: 8658: 8657: 8655: 8654: 8652: 8646: 8636: 8633: 8631: 8628: 8626: 8623: 8621: 8618: 8616: 8613: 8611: 8608: 8606: 8603: 8601: 8598: 8596: 8593: 8591: 8588: 8586: 8583: 8581: 8578: 8576: 8573: 8569: 8566: 8564: 8561: 8560: 8559: 8556: 8554: 8551: 8549: 8546: 8545: 8543: 8541:in population 8537: 8531: 8528: 8526: 8523: 8521: 8518: 8516: 8513: 8511: 8508: 8506: 8505:Herd immunity 8503: 8501: 8498: 8496: 8493: 8491: 8488: 8486: 8483: 8481: 8478: 8476: 8473: 8471: 8468: 8467: 8465: 8463: 8459: 8441: 8438: 8437: 8435: 8431: 8424: 8423: 8421: 8417: 8410: 8409: 8407: 8403: 8397: 8394: 8393: 8391: 8389:Genitourinary 8387: 8381: 8377: 8375: 8372: 8370: 8367: 8365: 8362: 8361: 8359: 8355: 8349: 8346: 8344: 8341: 8339: 8336: 8332: 8331:Contamination 8329: 8328: 8327: 8324: 8323: 8321: 8317: 8309: 8306: 8304: 8301: 8300: 8299:Vector-borne 8298: 8294: 8291: 8289: 8286: 8285: 8283: 8279: 8276: 8273: 8271: 8268: 8266: 8263: 8262: 8260: 8258: 8255: 8254: 8252: 8246: 8240: 8237: 8235: 8232: 8228: 8225: 8224: 8223: 8220: 8218: 8215: 8214: 8212: 8208: 8205: 8201: 8195: 8192: 8191: 8189: 8183: 8177: 8174: 8170: 8167: 8163: 8160: 8157: 8154: 8153: 8152: 8149: 8148: 8146: 8142: 8139: 8137: 8134: 8133: 8131: 8129: 8126: 8125: 8123: 8119: 8115: 8109: 8106: 8104: 8101: 8099: 8096: 8094: 8091: 8090: 8088: 8086: 8085:Cross-species 8082: 8079: 8075: 8068: 8065: 8062: 8059: 8057: 8054: 8052: 8049: 8046: 8045: 8043: 8039: 8036: 8032: 8026: 8025:Window period 8023: 8021: 8018: 8016: 8013: 8011: 8008: 8006: 8003: 8001: 7998: 7996: 7993: 7991: 7990:Latent period 7988: 7986: 7983: 7981: 7978: 7976: 7973: 7971: 7968: 7966: 7963: 7961: 7958: 7956: 7953: 7952: 7950: 7944: 7941: 7939: 7935: 7925: 7922: 7920: 7917: 7915: 7912: 7910: 7907: 7905: 7902: 7900: 7897: 7893: 7890: 7889: 7887: 7885: 7882: 7880: 7877: 7875: 7872: 7870: 7869:Deforestation 7867: 7865: 7862: 7858: 7855: 7853: 7850: 7849: 7847: 7845: 7842: 7839: 7836: 7834: 7831: 7830: 7828: 7826: 7822: 7814:Stress levels 7813: 7810: 7806: 7803: 7802: 7800: 7797: 7794: 7791: 7788: 7785: 7784: 7783: 7780: 7778: 7775: 7773: 7770: 7768: 7765: 7761: 7758: 7756: 7753: 7752: 7751: 7748: 7746: 7743: 7741: 7738: 7736: 7733: 7731: 7728: 7727: 7725: 7723: 7719: 7713: 7710: 7706: 7703: 7701: 7698: 7696: 7693: 7692: 7691: 7688: 7684: 7681: 7679: 7676: 7674: 7671: 7669: 7666: 7665: 7664: 7661: 7659: 7656: 7652: 7649: 7648: 7647: 7646:Pathogenicity 7644: 7640: 7637: 7636: 7635: 7632: 7630: 7627: 7625: 7622: 7621: 7619: 7617: 7613: 7610: 7606: 7601: 7597: 7589: 7584: 7582: 7577: 7575: 7570: 7569: 7566: 7550: 7548: 7545: 7544: 7542: 7539: 7536: 7533: 7531: 7528: 7527: 7523: 7513: 7510: 7508: 7505: 7503: 7500: 7498: 7495: 7494: 7492: 7488: 7482: 7479: 7477: 7474: 7472: 7469: 7467: 7464: 7462: 7459: 7457: 7454: 7452: 7449: 7447: 7444: 7442: 7439: 7437: 7434: 7432: 7429: 7427: 7424: 7422: 7419: 7417: 7414: 7413: 7411: 7407: 7400: 7396: 7393: 7391: 7388: 7385: 7381: 7378: 7376: 7373: 7371: 7368: 7366: 7363: 7362: 7360: 7357: 7353: 7347: 7344: 7342: 7339: 7337: 7334: 7333: 7331: 7329: 7325: 7322: 7318: 7311: 7307: 7304: 7302: 7299: 7297: 7293: 7292: 7291:release phase 7288: 7284: 7283: 7279: 7276: 7274: 7271: 7269: 7265: 7264: 7263:M2 inhibitors 7260: 7256: 7255: 7252: 7249: 7247: 7244: 7242: 7239: 7238: 7236: 7233: 7228: 7222: 7219: 7217: 7213: 7212: 7210: 7208: 7204: 7198: 7195: 7194: 7192: 7190: 7186: 7176: 7173: 7171: 7168: 7166: 7163: 7161: 7158: 7156: 7153: 7151: 7148: 7146: 7143: 7142: 7140: 7136: 7130: 7127: 7125: 7122: 7120: 7117: 7115: 7112: 7110: 7107: 7105: 7102: 7100: 7097: 7095: 7092: 7090: 7087: 7085: 7082: 7080: 7077: 7075: 7074:Bemnifosbuvir 7072: 7070: 7067: 7066: 7064: 7061: 7058: 7054: 7048: 7045: 7043: 7040: 7038: 7035: 7033: 7030: 7028: 7025: 7023: 7020: 7018: 7015: 7013: 7010: 7008: 7005: 7003: 7000: 6998: 6995: 6994: 6992: 6989: 6985: 6979: 6976: 6974: 6971: 6969: 6966: 6964: 6961: 6959: 6956: 6954: 6951: 6949: 6946: 6944: 6941: 6939: 6936: 6934: 6931: 6929: 6926: 6924: 6921: 6919: 6916: 6914: 6911: 6909: 6906: 6905: 6903: 6900: 6896: 6892: 6889: 6887: 6883: 6878: 6874: 6870: 6866: 6863: 6856: 6851: 6849: 6844: 6842: 6837: 6836: 6833: 6817: 6815: 6812: 6811: 6809: 6806: 6803: 6800: 6798: 6795: 6794: 6790: 6780: 6777: 6775: 6771: 6768: 6766: 6763: 6762: 6760: 6756: 6750: 6747: 6745: 6742: 6741: 6739: 6737: 6733: 6727: 6726:Brincidofovir 6724: 6722: 6719: 6718: 6716: 6712: 6709: 6705: 6699: 6696: 6694: 6691: 6689: 6686: 6684: 6680: 6676: 6675: 6672: 6669: 6667: 6664: 6662: 6659: 6657: 6654: 6652: 6649: 6647: 6643: 6639: 6638: 6636: 6633: 6629: 6619: 6616: 6614: 6611: 6610: 6608: 6606: 6602: 6596: 6593: 6591: 6587: 6586: 6584: 6582: 6578: 6572: 6569: 6567: 6563: 6560: 6559: 6557: 6555: 6551: 6547: 6537: 6534: 6531: 6527: 6526: 6525:early protein 6522: 6520: 6517: 6515: 6512: 6510: 6507: 6505: 6502: 6501: 6499: 6495: 6485: 6482: 6481: 6479: 6475: 6464: 6460: 6459: 6455: 6454: 6449: 6446: 6444: 6441: 6439: 6436: 6435: 6434: 6433: 6429: 6428: 6424: 6421: 6418: 6414: 6411: 6409: 6405: 6404: 6400: 6399: 6397: 6395: 6391: 6384: 6380: 6379: 6375: 6374: 6370: 6366: 6363: 6361: 6357: 6354: 6352: 6348: 6344: 6343: 6339: 6338: 6336: 6334: 6330: 6327: 6324: 6320: 6317: 6313:DNA-synthesis 6311: 6308: 6306: 6302: 6299: 6297: 6293: 6288: 6284: 6280: 6276: 6273: 6266: 6261: 6259: 6254: 6252: 6247: 6246: 6243: 6231: 6228: 6225: 6215: 6213: 6210: 6209: 6207: 6204: 6201: 6198: 6196: 6193: 6192: 6188: 6178: 6175: 6173: 6170: 6168: 6165: 6163: 6160: 6158: 6155: 6153: 6150: 6148: 6145: 6143: 6140: 6138: 6135: 6133: 6130: 6128: 6125: 6123: 6120: 6118: 6115: 6113: 6110: 6109: 6107: 6105:Failed agents 6103: 6097: 6094: 6092: 6089: 6087: 6084: 6082: 6079: 6077: 6074: 6072: 6069: 6067: 6064: 6062: 6059: 6057: 6054: 6052: 6049: 6047: 6044: 6042: 6039: 6037: 6034: 6032: 6029: 6027: 6024: 6022: 6019: 6017: 6014: 6012: 6009: 6007: 6004: 6003: 6001: 5997: 5991: 5988: 5987: 5985: 5983: 5979: 5973: 5972:Trichosanthin 5970: 5969: 5967: 5965: 5961: 5955: 5952: 5951: 5949: 5947: 5943: 5936: 5933: 5932: 5930: 5928: 5924: 5921: 5917: 5911: 5910:Ritonavir (r) 5908: 5906: 5903: 5902: 5900: 5896: 5890: 5887: 5885: 5882: 5880: 5877: 5875: 5872: 5870: 5867: 5865: 5862: 5860: 5857: 5855: 5852: 5850: 5847: 5845: 5842: 5840: 5837: 5835: 5832: 5830: 5827: 5825: 5822: 5820: 5817: 5815: 5812: 5809: 5806: 5803: 5800: 5797: 5794: 5792: 5789: 5786: 5783: 5781: 5778: 5776: 5773: 5770: 5767: 5765: 5762: 5760: 5757: 5754: 5751: 5749: 5746: 5745: 5743: 5741: 5737: 5723: 5720: 5718: 5715: 5711: 5708: 5706: 5703: 5701: 5698: 5697: 5696: 5695: 5691: 5690: 5688: 5684: 5678: 5675: 5673: 5670: 5668: 5665: 5664: 5662: 5658: 5655: 5653: 5651: 5645: 5641: 5635: 5632: 5630: 5627: 5625: 5621: 5617: 5616: 5613: 5610: 5608: 5605: 5603: 5600: 5598: 5595: 5593: 5590: 5588: 5585: 5583: 5580: 5578: 5575: 5573: 5570: 5568: 5565: 5563: 5560: 5558: 5555: 5553: 5550: 5548: 5545: 5543: 5539: 5535: 5534: 5532: 5530: 5524: 5521: 5518: 5512: 5502: 5499: 5497: 5494: 5491: 5488: 5485: 5482: 5481: 5479: 5475: 5469: 5466: 5464: 5461: 5459: 5456: 5454: 5451: 5449: 5446: 5444: 5441: 5439: 5436: 5435: 5433: 5429: 5426: 5424: 5422: 5416: 5412: 5406: 5403: 5401: 5398: 5396: 5393: 5392: 5390: 5388: 5384: 5378: 5375: 5373: 5370: 5368: 5365: 5363: 5360: 5358: 5355: 5353: 5350: 5348: 5345: 5344: 5342: 5338: 5334: 5327: 5323: 5322: 5318: 5315: 5311: 5307: 5306: 5302: 5299: 5295: 5291: 5288: 5286: 5282: 5281: 5277: 5274: 5270: 5269: 5265: 5264: 5262: 5260: 5258: 5252: 5248: 5242: 5239: 5238: 5236: 5234: 5230: 5225: 5221: 5218:used against 5217: 5213: 5206: 5201: 5199: 5194: 5192: 5187: 5186: 5183: 5171: 5166: 5162: 5160: 5157: 5155: 5152: 5150: 5141: 5140: 5137: 5131: 5128: 5126: 5123: 5121: 5118: 5116: 5113: 5111: 5108: 5107: 5105: 5102: 5098: 5093: 5087: 5084: 5082: 5079: 5078: 5076: 5073: 5069: 5065: 5059: 5052: 5050: 5047: 5045: 5042: 5040: 5039:Decongestants 5037: 5036: 5034: 5031: 5027: 5021: 5015: 5012: 5010: 5007: 5005: 5002: 5000: 4997: 4995: 4992: 4990: 4987: 4985: 4982: 4980: 4977: 4975: 4971: 4968: 4964: 4961: 4959: 4958:Dissociatives 4956: 4954: 4951: 4950: 4949: 4948:Hallucinogens 4946: 4944: 4941: 4939: 4936: 4934: 4931: 4929: 4926: 4924: 4921: 4919: 4916: 4914: 4911: 4909: 4906: 4904: 4901: 4899: 4896: 4894: 4891: 4889: 4886: 4884: 4881: 4879: 4876: 4874: 4871: 4867: 4864: 4862: 4859: 4858: 4857: 4854: 4852: 4849: 4848: 4846: 4843: 4839: 4834: 4830: 4824: 4821: 4819: 4816: 4814: 4811: 4809: 4806: 4802: 4799: 4798: 4797: 4794: 4792: 4789: 4788: 4786: 4783: 4779: 4773: 4769: 4765: 4757: 4754: 4752: 4749: 4748: 4747: 4744: 4743: 4741: 4738: 4732: 4728: 4720: 4717: 4715: 4712: 4710: 4707: 4705: 4702: 4700: 4697: 4696: 4695: 4692: 4691: 4689: 4686: 4680: 4676: 4670: 4667: 4665: 4662: 4658: 4655: 4653: 4652:Anthelmintics 4650: 4648: 4645: 4644: 4643: 4640: 4638: 4635: 4633: 4630: 4627: 4623: 4619: 4616: 4615: 4613: 4610: 4606: 4602: 4598: 4593: 4589: 4583: 4579: 4576: 4574: 4571: 4567: 4564: 4562: 4559: 4558: 4557: 4554: 4552: 4549: 4548: 4546: 4543: 4539: 4533: 4527: 4524: 4522: 4519: 4517: 4514: 4512: 4509: 4508: 4506: 4503: 4499: 4496:genitourinary 4493: 4487: 4484: 4482: 4479: 4477: 4476:Antipruritics 4474: 4472: 4469: 4467: 4464: 4463: 4461: 4458: 4454: 4450: 4442: 4439: 4437: 4434: 4432: 4429: 4428: 4427: 4424: 4420: 4417: 4415: 4412: 4410: 4407: 4406: 4405: 4404: 4400: 4398: 4395: 4393: 4392:Beta blockers 4390: 4388: 4385: 4383: 4380: 4378: 4375: 4371: 4368: 4366: 4363: 4361: 4358: 4357: 4356: 4355: 4350: 4349: 4347: 4344: 4340: 4334: 4326: 4323: 4321: 4318: 4316: 4313: 4312: 4311: 4308: 4304: 4301: 4299: 4296: 4294: 4293:Antiplatelets 4291: 4290: 4289: 4286: 4285: 4283: 4280: 4274: 4270: 4264: 4261: 4259: 4256: 4254: 4251: 4249: 4246: 4244: 4240: 4237: 4235: 4232: 4230: 4227: 4223: 4220: 4218: 4211: 4209: 4206: 4205: 4204: 4201: 4200: 4198: 4195: 4191: 4186: 4182: 4178: 4170: 4165: 4163: 4158: 4156: 4151: 4150: 4147: 4129: 4125: 4119: 4104: 4100: 4094: 4086: 4082: 4075: 4067: 4060: 4041: 4034: 4027: 4025: 4016: 4012: 4007: 4002: 3997: 3992: 3988: 3984: 3980: 3976: 3972: 3965: 3957: 3953: 3948: 3943: 3938: 3933: 3929: 3925: 3921: 3914: 3906: 3902: 3898: 3894: 3890: 3886: 3879: 3871: 3867: 3863: 3859: 3851: 3849: 3840: 3836: 3832: 3824: 3815: 3810: 3805: 3800: 3796: 3792: 3788: 3781: 3772: 3767: 3763: 3759: 3755: 3747: 3738: 3733: 3728: 3723: 3719: 3715: 3711: 3704: 3696: 3690: 3682: 3678: 3673: 3668: 3664: 3660: 3656: 3652: 3648: 3641: 3633: 3629: 3624: 3619: 3614: 3609: 3605: 3601: 3597: 3590: 3582: 3576: 3574: 3565: 3561: 3556: 3551: 3547: 3543: 3540:(2): 413–37. 3539: 3535: 3531: 3524: 3516: 3512: 3508: 3504: 3499: 3494: 3490: 3486: 3482: 3475: 3467: 3463: 3458: 3453: 3449: 3445: 3442:(1): vew014. 3441: 3437: 3433: 3426: 3424: 3415: 3411: 3406: 3401: 3398:(3): 403–21. 3397: 3393: 3389: 3382: 3374: 3370: 3365: 3360: 3356: 3352: 3348: 3344: 3340: 3333: 3325: 3321: 3316: 3311: 3307: 3303: 3299: 3293: 3285: 3281: 3276: 3271: 3267: 3263: 3259: 3255: 3251: 3244: 3229: 3228:Virology Blog 3225: 3218: 3216: 3199: 3198: 3190: 3188: 3179: 3175: 3171: 3165: 3157: 3153: 3149: 3143: 3139: 3135: 3131: 3124: 3116: 3112: 3108: 3104: 3100: 3096: 3093:(6): 510–13. 3092: 3088: 3081: 3066: 3062: 3057: 3052: 3048: 3044: 3040: 3033: 3025: 3021: 3016: 3011: 3007: 3003: 2999: 2995: 2991: 2984: 2982: 2980: 2971: 2967: 2961: 2959: 2957: 2955: 2953: 2951: 2949: 2947: 2930: 2926: 2922: 2918: 2914: 2910: 2906: 2902: 2898: 2894: 2887: 2879: 2875: 2871: 2867: 2863: 2859: 2856:(6): 639–43. 2855: 2851: 2844: 2836: 2832: 2828: 2824: 2820: 2816: 2812: 2808: 2801: 2793: 2789: 2784: 2779: 2775: 2771: 2767: 2763: 2759: 2752: 2744: 2740: 2735: 2730: 2726: 2722: 2718: 2714: 2710: 2706: 2700: 2692: 2688: 2683: 2678: 2673: 2668: 2664: 2660: 2657:(7): e22572. 2656: 2652: 2648: 2641: 2633: 2629: 2625: 2621: 2618:(1): 367–73. 2617: 2613: 2605: 2597: 2593: 2588: 2583: 2580:(3): 915–23. 2579: 2575: 2571: 2564: 2556: 2552: 2547: 2542: 2538: 2534: 2530: 2526: 2522: 2515: 2507: 2503: 2498: 2493: 2489: 2483: 2479: 2475: 2471: 2464: 2456: 2452: 2448: 2444: 2439: 2434: 2431:(1): 207–11. 2430: 2426: 2422: 2415: 2407: 2403: 2399: 2395: 2392:(5): 385–99. 2391: 2387: 2380: 2372: 2368: 2363: 2358: 2355:(6): 538–44. 2354: 2350: 2346: 2339: 2331: 2327: 2322: 2317: 2313: 2309: 2305: 2301: 2297: 2290: 2282: 2278: 2274: 2270: 2265: 2260: 2257:(2): 503–08. 2256: 2252: 2248: 2241: 2233: 2229: 2224: 2219: 2215: 2211: 2207: 2203: 2199: 2192: 2184: 2180: 2175: 2170: 2166: 2162: 2158: 2154: 2150: 2143: 2135: 2131: 2127: 2123: 2120:(5): 317–25. 2119: 2115: 2108: 2100: 2093: 2077: 2073: 2067: 2059: 2052: 2044: 2040: 2035: 2030: 2026: 2022: 2018: 2014: 2010: 2003: 1995: 1989: 1985: 1978: 1970: 1966: 1961: 1956: 1952: 1948: 1944: 1940: 1936: 1929: 1921: 1917: 1913: 1909: 1905: 1901: 1898:(6): 261–71. 1897: 1893: 1892:Intervirology 1886: 1879: 1875: 1871: 1865: 1861: 1857: 1853: 1846: 1838: 1834: 1829: 1824: 1820: 1816: 1813:(3): 285–99. 1812: 1808: 1804: 1797: 1781: 1775: 1767: 1763: 1758: 1753: 1749: 1745: 1741: 1737: 1733: 1726: 1718: 1714: 1709: 1704: 1700: 1696: 1691: 1686: 1682: 1678: 1674: 1667: 1665: 1656: 1652: 1648: 1644: 1640: 1636: 1632: 1628: 1624: 1620: 1616: 1608: 1600: 1596: 1592: 1588: 1584: 1580: 1576: 1569: 1560: 1555: 1551: 1545: 1541: 1537: 1533: 1526: 1524: 1515: 1511: 1506: 1501: 1496: 1491: 1487: 1483: 1479: 1472: 1464: 1460: 1455: 1450: 1446: 1442: 1438: 1434: 1430: 1423: 1415: 1411: 1408:(4): 343–47. 1407: 1403: 1402:Die Pharmazie 1396: 1388: 1384: 1379: 1374: 1369: 1364: 1360: 1356: 1352: 1348: 1344: 1337: 1329: 1322: 1314: 1310: 1305: 1300: 1295: 1290: 1286: 1282: 1281:Antiviral Res 1278: 1271: 1263: 1259: 1255: 1249: 1245: 1235: 1232: 1230: 1227: 1225: 1221: 1218: 1216: 1213: 1211: 1208: 1206: 1203: 1200: 1197: 1195: 1192: 1189: 1186: 1185: 1181: 1175: 1170: 1163: 1160: 1156: 1152: 1148: 1143: 1133: 1131: 1127: 1123: 1119: 1115: 1102:Public policy 1099: 1097: 1093: 1089: 1085: 1081: 1077: 1073: 1068: 1066: 1061: 1057: 1053: 1045: 1042: 1039: 1036: 1033: 1030: 1027: 1024: 1021: 1018: 1017: 1016: 1013: 1011: 1007: 1003: 999: 995: 991: 981: 977: 968: 965: 954: 950: 948: 944: 939: 935: 932: 921: 918: 917: 912: 908: 904: 899: 896: 892: 888: 883: 881: 876: 867: 865: 861: 856: 854: 849: 844: 834: 832: 831:neuraminidase 828: 824: 817:Release phase 814: 812: 803: 801: 797: 792: 788: 784: 780: 776: 772: 768: 764: 760: 756: 752: 751: 746: 742: 738: 728: 726: 722: 718: 713: 711: 707: 697: 689: 686: 681: 679: 667: 666:coronaviruses 664: 662: 659: 657: 654: 651: 647: 644: 642: 641:caliciviruses 639: 638: 637: 634: 632: 628: 624: 613: 611: 607: 606:messenger RNA 600:Transcription 597: 595: 591: 587: 583: 573: 571: 566: 564: 559: 557: 553: 548: 546: 542: 538: 534: 530: 520: 512: 509: 505: 501: 496: 494: 493: 486: 484: 480: 476: 472: 471:enteroviruses 468: 464: 460: 456: 454: 450: 446: 438: 434: 432: 426: 424: 420: 416: 410: 400: 393: 389: 386: 382: 378: 377: 376: 373: 371: 358: 355: 352: 349: 346: 345: 344: 341: 339: 334: 332: 328: 324: 320: 316: 313:consist of a 312: 303: 301: 297: 292: 290: 285: 270: 267: 259: 248: 245: 241: 238: 234: 231: 227: 224: 220: 217: â€“  216: 212: 211:Find sources: 205: 201: 195: 194: 189:This section 187: 183: 178: 177: 169: 167: 163: 158: 155: 151: 146: 144: 138: 134: 132: 128: 125:viruses, and 124: 120: 116: 112: 102: 100: 96: 92: 88: 85: 81: 77: 76:antiparasitic 73: 69: 65: 61: 57: 53: 49: 45: 37: 33: 29: 22: 8982:Notification 8953:Hand washing 8948:Food hygiene 8933:Disinfection 8829:Immunization 8808: 8780:Anthelmintic 8768:prophylactic 8656:Respiratory 8580:Hyperendemic 8530:WAIFW matrix 8185:Environment- 7938:Transmission 7914:Urbanization 7712:Host tropism 7608:Determinants 7594:Concepts in 7456:Molnupiravir 7451:Mericitabine 7421:Deuremidevir 7395:Simnotrelvir 7380:Nirmatrelvir 7370:Ibuzatrelvir 7356:3CL protease 7285: 7257: 7214: 7207:Picornavirus 7129:Uprifosbuvir 7027:Pibrentasvir 6978:Voxilaprevir 6948:Paritaprevir 6864: 6765:Filociclovir 6677: 6640: 6588: 6536:Tromantadine 6523: 6456: 6430: 6413:Trifluridine 6401: 6376: 6351:Valaciclovir 6340: 6274: 6226: 6026:Cyanovirin-N 6016:Calanolide A 5692: 5686:2 generation 5660:1 generation 5647: 5618: 5597:Elvucitabine 5587:Apricitabine 5536: 5477:2 generation 5431:1 generation 5418: 5405:Fipravirimat 5319: 5314:Semzuvolimab 5303: 5294:Cenicriviroc 5278: 5266: 5254: 5211: 4953:Psychedelics 4923:Aphrodisiacs 4636: 4597:infestations 4573:Sex hormones 4526:Sex hormones 4471:Cicatrizants 4401: 4387:Vasodilators 4354:antianginals 4351: 4203:stomach acid 4202: 4131:. Retrieved 4127: 4118: 4106:. Retrieved 4102: 4093: 4084: 4074: 4059: 4047:. Retrieved 4040:the original 3978: 3974: 3964: 3927: 3923: 3913: 3888: 3884: 3878: 3861: 3857: 3838: 3834: 3823: 3794: 3790: 3780: 3764:(1): 41–45. 3761: 3757: 3746: 3717: 3713: 3703: 3689: 3654: 3650: 3640: 3603: 3599: 3589: 3537: 3533: 3523: 3488: 3484: 3474: 3439: 3435: 3395: 3391: 3381: 3346: 3342: 3332: 3305: 3301: 3292: 3257: 3253: 3243: 3231:. Retrieved 3227: 3202:. Retrieved 3196: 3178:the original 3173: 3164: 3129: 3123: 3090: 3086: 3080: 3068:. Retrieved 3046: 3042: 3032: 2997: 2993: 2969: 2933:. Retrieved 2929:the original 2900: 2896: 2886: 2853: 2849: 2843: 2813:(1): 53–65. 2810: 2806: 2800: 2765: 2761: 2751: 2716: 2712: 2699: 2654: 2650: 2640: 2615: 2611: 2604: 2577: 2573: 2563: 2531:(1): 65–77. 2528: 2524: 2514: 2469: 2463: 2428: 2424: 2414: 2389: 2385: 2379: 2352: 2348: 2338: 2303: 2299: 2289: 2254: 2250: 2240: 2205: 2201: 2191: 2156: 2152: 2142: 2117: 2113: 2107: 2092: 2080:. Retrieved 2076:the original 2066: 2051: 2016: 2012: 2002: 1983: 1977: 1942: 1938: 1928: 1895: 1891: 1885: 1851: 1845: 1810: 1806: 1796: 1784:. Retrieved 1774: 1739: 1735: 1725: 1680: 1676: 1622: 1618: 1607: 1582: 1578: 1568: 1531: 1485: 1481: 1471: 1436: 1432: 1422: 1405: 1401: 1395: 1350: 1346: 1336: 1327: 1321: 1284: 1280: 1270: 1253: 1248: 1194:CRISPR-Cas13 1145: 1110: 1069: 1049: 1014: 993: 989: 987: 978: 974: 960: 951: 947:reassortment 940: 936: 927: 914: 900: 884: 873: 857: 850: 846: 820: 809: 786: 759:oligomerizer 748: 734: 724: 720: 714: 703: 695: 682: 675: 646:flaviviruses 635: 619: 603: 594:dolutegravir 590:elvitegravir 579: 567: 560: 549: 526: 518: 508:adenoviruses 497: 490: 487: 483:encephalitis 463:rhinoviruses 457: 447: 444: 435: 427: 412: 397: 374: 367: 342: 335: 309: 293: 286: 282: 262: 253: 243: 236: 229: 222: 210: 198:Please help 193:verification 190: 162:side effects 159: 147: 139: 135: 108: 105:Medical uses 43: 42: 32: 9235:Eradication 9146:Biosecurity 8871:Vaccination 8846:Inoculation 8824:Drug safety 8819:Combination 8746:and Control 8694:Soft tissue 8648:Anatomical 8615:Seasonality 8595:Mesoendemic 8575:Holoendemic 8568:Farr's laws 8480:Attack rate 8278:Animal bite 8274:Insect bite 8210:Respiratory 7837:Air quality 7825:Environment 7735:Comorbidity 7651:Attack rate 7634:Infectivity 7537:from market 7502:Merimepodib 7476:Triazavirin 7471:Taribavirin 7431:Galidesivir 7426:Favipiravir 7390:Rupintrivir 7375:Lufotrelvir 7365:Ensitrelvir 7310:Laninamivir 7296:Oseltamivir 7278:Rimantadine 7216:viral entry 7197:Bulevirtide 7189:Hepatitis D 7047:Velpatasvir 7002:Daclatasvir 6997:Coblopasvir 6973:Vedroprevir 6943:Narlaprevir 6938:Grazoprevir 6933:Glecaprevir 6928:Faldaprevir 6908:Asunaprevir 6886:Hepatitis C 6867:(primarily 6804:from market 6774:Taribavirin 6666:Telbivudine 6632:Hepatitis B 6618:Tecovirimat 6613:Methisazone 6408:Idoxuridine 6369:Famciclovir 6365:Penciclovir 6356:Ganciclovir 6305:Herpesvirus 6296:Baltimore I 6277:(primarily 6227:recommended 6202:from market 6152:Lersivirine 6127:Capravirine 6066:Miltefosine 6051:Griffithsin 6046:Fosdevirine 5592:Censavudine 5222:(primarily 5086:Otologicals 5058:antagonists 5024:respiratory 4999:Orexigenics 4994:Neurotoxins 4943:Euphoriants 4933:Entactogens 4928:Depressants 4918:Anxiolytics 4856:Anesthetics 4632:Antifungals 4229:Antiemetics 4217:antagonists 3349:(1): 6–10. 3174:www.who.int 1136:Stockpiling 998:hepatitis C 905:(Tamiflu), 903:oseltamivir 895:influenza B 891:influenza A 853:interferons 827:oseltamivir 796:procaspases 685:hepatitis C 648:(including 633:antisense. 586:raltegravir 467:common cold 453:rimantadine 431:Enfuvirtide 415:viral entry 127:influenza A 119:hepatitis B 9285:Categories 9118:infections 9059:Sanitation 9027:Quarantine 8886:resistance 8804:Antiseptic 8785:Ascaricide 8775:Antifungal 8763:Antibiotic 8744:Prevention 8677:Intestinal 8610:Prevalence 8590:Inequality 8539:Occurrence 8338:Breastmilk 8222:Bioaerosol 8194:Sapronosis 8169:Horizontal 8041:Endogenous 8020:Viral load 7980:Index case 7512:Presatovir 7507:Moroxydine 7441:Remdesivir 7399:+ritonavir 7384:+ritonavir 7328:Interferon 7273:Amantadine 7268:Adapromine 7251:Umifenovir 7221:Pleconaril 7124:Radalbuvir 7119:TMC-647055 7109:Sofosbuvir 7104:Setrobuvir 7084:Deleobuvir 7069:Beclabuvir 7042:Samatasvir 7032:Ravidasvir 7022:Ombitasvir 7012:Ledipasvir 6968:Vaniprevir 6963:Telaprevir 6958:Sovaprevir 6953:Simeprevir 6923:Danoprevir 6918:Ciluprevir 6913:Boceprevir 6865:antivirals 6779:Moroxydine 6736:Interferon 6656:Lamivudine 6605:Poxviridae 6595:Rifampicin 6566:Resiquimod 6530:Fomivirsen 6514:Letermovir 6504:Amenamevir 6463:Cytarabine 6448:Sorivudine 6417:+tipiracil 6383:Vidarabine 6275:antivirals 6157:Lodenosine 6137:Droxinavir 6122:Brecanavir 6117:Atevirdine 6081:Seliciclib 6076:Scytovirin 5990:Elipovimab 5935:TRIM5alpha 5612:Stampidine 5517:inhibitors 5501:TMC-310911 5400:BMS-955176 5298:Leronlimab 5290:Vicriviroc 5009:Stimulants 4989:Nootropics 4963:Deliriants 4938:Entheogens 4873:Anorectics 4851:Analgesics 4704:Alkylating 4637:Antivirals 4592:infections 4466:Emollients 4320:Coagulants 4190:metabolism 4133:21 October 4108:21 October 4066:"H1N1 Flu" 4049:21 October 3858:Hepatology 3758:Hepatology 3233:1 December 3204:1 December 3070:30 October 2935:31 October 2251:Hepatology 1683:(3): 850. 1488:(4): 810. 1287:: 94–103. 1240:References 1224:Astemizole 1126:H1N1 virus 1080:letermovir 1006:interferon 860:antibodies 811:Rifampicin 783:rhinovirus 775:bunyavirus 771:arenavirus 745:base pairs 719:mushroom ( 631:morpholino 623:fomivirsen 563:lamivudine 556:zidovudine 533:nucleoside 529:nucleotide 475:meningitis 459:Pleconaril 449:Amantadine 392:antibodies 325:(called a 226:newspapers 95:eucalyptus 87:infections 72:antifungal 68:antibiotic 58:, while a 48:medication 9230:Discovery 9156:Disease X 9116:Emerging 9064:Screening 8965:Isolation 8809:Antiviral 8635:Twindemic 8585:Incidence 8462:Modelling 8425:Perinatal 8357:Cutaneous 8248:Linked to 8158:Perinatal 8077:Exogenous 8069:formation 7811:Pregnancy 7668:Endotoxin 7663:Virulence 7547:Phase III 7535:Withdrawn 7466:Ribavirin 7436:GS-441524 7306:Peramivir 7301:Zanamivir 7246:Pimodivir 7232:influenza 7114:Tegobuvir 7089:Filibuvir 7079:Dasabuvir 7017:Odalasvir 6862:RNA virus 6814:Phase III 6802:Withdrawn 6770:Ribavirin 6721:Cidofovir 6671:Clevudine 6661:Lobucavir 6651:Entecavir 6562:Imiquimod 6519:Maribavir 6509:Docosanol 6484:Foscarnet 6438:Brivudine 6423:Edoxudine 6347:Aciclovir 6325:activated 6315:inhibitor 6272:DNA virus 6212:Phase III 6200:Withdrawn 6177:Telinavir 6172:Palinavir 6167:Mozenavir 6147:Emivirine 6142:Lasinavir 6112:Aplaviroc 6041:Foscarnet 6021:Ceragenin 5582:Amdoxovir 5395:Bevirimat 5372:BI 224436 5159:ATC codes 5125:Dressings 5110:Antidotes 4974:Sedatives 4970:Hypnotics 4679:malignant 4536:endocrine 4382:Diuretics 4315:Platelets 4275:and blood 4234:Laxatives 3930:(1): 32. 3515:205104988 2835:260319327 2425:FEBS Lett 2082:8 January 1878:181538245 1786:7 January 1699:1420-3049 1677:Molecules 1655:143434120 1639:0022-2623 1599:1665-5796 1201:(for HIV) 1090:(against 1082:(against 1074:(against 1072:aciclovir 1010:genotypes 1002:ribavirin 988:The term 976:viruses. 931:pneumonia 911:peramivir 907:zanamivir 823:zanamivir 791:apoptosis 741:mammalian 678:ribozymes 582:integrase 576:Integrase 552:aciclovir 495:in 2016. 291:program. 133:viruses. 91:virucides 9296:Biocides 9139:EARS-Net 9054:Safe sex 9006:services 8977:Lockdown 8748:measures 8650:location 8630:Syndemic 8625:Sporadic 8605:Pandemic 8600:Outbreak 8558:Epidemic 8411:Prenatal 8303:Mosquito 8187:to-human 8162:Neonatal 8155:Prenatal 8103:Zoonosis 7948:concepts 7879:Humidity 7864:Commerce 7740:Diabetes 7673:Exotoxin 7037:Ruzasvir 7007:Elbasvir 6688:Adefovir 6590:assembly 6581:Vaccinia 6458:cytosine 6162:Loviride 5004:Serenics 4669:Vaccines 4436:Fibrates 4258:Vitamins 4208:Antacids 4015:25807314 3975:PLOS ONE 3956:26473026 3905:34636311 3681:28319996 3632:26819511 3564:20466277 3507:19258250 3466:28694997 3373:21148489 3324:29588540 3284:19906671 3156:19048205 3115:22710439 3107:19513050 3065:20375034 2925:71595650 2917:18847315 2870:18978532 2827:19235659 2792:11585785 2713:J. Virol 2705:Sodeik B 2691:21818340 2651:PLOS ONE 2596:10411656 2555:19171928 2506:19048198 2455:43114821 2406:11282007 2371:14659071 2330:15140987 2300:J. Virol 2273:12883495 2232:15795296 2202:J. Virol 2183:15795246 2134:11763348 2043:10471549 1939:J. Virol 1920:21222121 1912:10325536 1837:16136207 1766:32679173 1717:35164129 1647:31050421 1514:33557246 1463:33726557 1414:11338678 1387:12799460 1313:25108173 1262:31643973 1256:. 2012. 1215:Virucide 1166:See also 1038:Zepatier 806:Assembly 800:caspases 773:, Guama 725:in vitro 717:shiitake 706:protease 511:degree. 370:receptor 300:bacteria 8943:Hygiene 8881:booster 8814:Asepsis 8553:Endemic 8548:Cluster 8132:Source 8067:Biofilm 7904:Poverty 7874:Ecology 7852:El Niño 7805:Smoking 7683:factors 7624:Biofilm 7600:Outline 7461:NITD008 7099:IDX-184 7094:GS-6620 6871:, also 6432:thymine 6403:uridine 6378:adenine 6342:guanine 6281:, also 6061:KP-1461 5607:Racivir 5377:MK-2048 4861:General 4768:muscles 4737:L03–L04 4733:disease 4685:L01–L02 4681:disease 4431:Statins 4006:4373943 3983:Bibcode 3947:4606524 3814:4530725 3737:4299677 3672:5486987 3623:4721977 3555:2871161 3457:5499642 3414:9182098 3364:3086431 3275:2842737 3024:9728000 3015:1113839 2878:3065481 2743:8289340 2682:3144912 2659:Bibcode 2632:2469420 2546:3170409 2497:7120715 2447:2834223 2281:1612244 2223:1069583 2174:1069577 1969:1850030 1828:1193547 1757:7361119 1708:8839652 1559:7120554 1505:7913928 1454:7975490 1355:Bibcode 1304:7113776 1044:Mavyret 1026:Epclusa 1020:Harvoni 787:in vivo 570:RNase H 421:" and " 385:ligands 323:protein 319:enzymes 311:Viruses 240:scholar 56:viruses 9151:CRISPR 9103:Zoning 8958:Gloves 8369:Fomite 8203:Routes 8098:Vector 7965:Fomite 7946:Basic 7909:Travel 7789:Gender 7530:WHO-EM 7446:MK-608 7416:CMX521 7234:agents 6797:WHO-EM 6683:NtRTIs 6646:NARTIs 6443:FV-100 6195:WHO-EM 6011:BIT225 6006:Abzyme 5937:(gene) 5624:NtRTIs 5519:(RTIs) 5168:  5147:  5095:other 5026:system 4778:joints 4731:immune 4538:system 4498:system 4339:system 4013:  4003:  3954:  3944:  3903:  3811:  3734:  3679:  3669:  3630:  3620:  3562:  3552:  3513:  3505:  3464:  3454:  3412:  3371:  3361:  3322:  3282:  3272:  3154:  3144:  3113:  3105:  3063:  3022:  3012:  2923:  2915:  2876:  2868:  2833:  2825:  2790:  2780:  2741:  2734:236549 2731:  2689:  2679:  2630:  2594:  2553:  2543:  2504:  2494:  2484:  2453:  2445:  2404:  2369:  2328:  2321:415795 2318:  2279:  2271:  2230:  2220:  2181:  2171:  2132:  2041:  2031:  1990:  1967:  1960:240614 1957:  1918:  1910:  1876:  1866:  1835:  1825:  1782:. 2022 1764:  1754:  1715:  1705:  1697:  1653:  1645:  1637:  1597:  1556:  1546:  1512:  1502:  1461:  1451:  1412:  1385:  1378:164704 1375:  1311:  1301:  1260:  1086:), or 1032:Vosevi 656:dengue 592:, and 481:, and 327:capsid 315:genome 242:  235:  228:  221:  213:  117:, the 9223:Other 8731:Fetus 8726:Mouth 8721:Tooth 8716:Blood 8703:Joint 8563:Curve 8433:Other 8380:wound 8378:Open 8348:Feces 8343:Water 8034:Modes 7892:Flood 7616:Agent 7497:EICAR 7230:Anti- 6877:D06BB 6873:S01AD 6634:(VII) 6497:Other 6287:D06BB 6283:S01AD 5999:Other 5982:BNAbs 5542:NRTIs 5321:gp120 5149:Drugs 4866:Local 4833:brain 4772:bones 4273:blood 4043:(PDF) 4036:(PDF) 3720:(1). 3511:S2CID 3111:S2CID 2921:S2CID 2874:S2CID 2831:S2CID 2783:89003 2451:S2CID 2277:S2CID 2034:89431 1916:S2CID 1874:S2CID 1651:S2CID 750:DRACO 737:dsRNA 331:lipid 247:JSTOR 233:books 84:treat 8987:list 8908:Non- 8698:Bone 8690:Skin 8374:Soil 8364:Burn 8326:Food 8308:Tick 7970:Host 7730:Burn 7722:Host 7057:NS5B 6988:NS5A 6875:and 6285:and 6224:DHHS 5280:CCR5 5268:gp41 4776:and 4453:skin 4135:2016 4110:2016 4051:2016 4011:PMID 3952:PMID 3901:PMID 3835:JAMA 3677:PMID 3628:PMID 3560:PMID 3503:PMID 3462:PMID 3410:PMID 3369:PMID 3320:PMID 3280:PMID 3235:2018 3206:2018 3152:PMID 3142:ISBN 3103:PMID 3072:2018 3061:PMID 3020:PMID 2937:2018 2913:PMID 2866:PMID 2823:PMID 2788:PMID 2739:PMID 2687:PMID 2628:PMID 2592:PMID 2551:PMID 2502:PMID 2482:ISBN 2443:PMID 2402:PMID 2367:PMID 2326:PMID 2269:PMID 2228:PMID 2179:PMID 2130:PMID 2084:2022 2039:PMID 1988:ISBN 1965:PMID 1908:PMID 1864:ISBN 1833:PMID 1788:2024 1762:PMID 1713:PMID 1695:ISSN 1643:PMID 1635:ISSN 1595:ISSN 1544:ISBN 1510:PMID 1459:PMID 1410:PMID 1383:PMID 1347:PNAS 1309:PMID 1258:PMID 1222:and 885:The 781:and 506:and 451:and 423:CCR5 219:news 143:AIDS 129:and 121:and 97:and 74:and 9047:PPE 8735:Eye 8396:Sex 8217:Air 7786:Age 6895:NS3 6869:J05 6550:HPV 6279:J05 5305:CD4 5224:J05 5220:HIV 5097:ATC 4835:and 4594:and 4001:PMC 3991:doi 3942:PMC 3932:doi 3893:doi 3866:doi 3839:308 3809:PMC 3799:doi 3766:doi 3732:PMC 3722:doi 3667:PMC 3659:doi 3655:166 3618:PMC 3608:doi 3550:PMC 3542:doi 3493:doi 3489:360 3452:PMC 3444:doi 3400:doi 3359:PMC 3351:doi 3347:203 3310:doi 3270:PMC 3262:doi 3258:277 3134:doi 3095:doi 3051:doi 3010:PMC 3002:doi 2998:317 2994:BMJ 2970:CDC 2905:doi 2858:doi 2815:doi 2778:PMC 2770:doi 2729:PMC 2721:doi 2677:PMC 2667:doi 2620:doi 2616:160 2582:doi 2578:262 2541:PMC 2533:doi 2492:PMC 2474:doi 2433:doi 2429:231 2394:doi 2357:doi 2316:PMC 2308:doi 2259:doi 2218:PMC 2210:doi 2169:PMC 2161:doi 2122:doi 2029:PMC 2021:doi 1955:PMC 1947:doi 1900:doi 1856:doi 1823:PMC 1815:doi 1752:PMC 1744:doi 1703:PMC 1685:doi 1627:doi 1587:doi 1554:PMC 1536:doi 1500:PMC 1490:doi 1449:PMC 1441:doi 1373:PMC 1363:doi 1351:100 1299:PMC 1289:doi 1285:110 1088:AZT 1078:), 1060:RNA 964:WHO 661:HCV 541:DNA 539:or 537:RNA 531:or 419:CD4 202:by 145:). 111:HIV 9287:: 7543:: 7308:, 6899:4A 6810:: 6554:MC 6323:TK 6208:: 5312:, 5296:, 5292:, 5214:: 4972:/ 4770:, 4620:: 4609:QI 4607:, 4603:, 4580:/ 4241:/ 4188:/ 4126:. 4101:. 4083:. 4023:^ 4009:. 3999:. 3989:. 3979:10 3977:. 3973:. 3950:. 3940:. 3926:. 3922:. 3899:. 3889:21 3887:. 3862:69 3860:. 3847:^ 3837:. 3833:. 3807:. 3795:61 3793:. 3789:. 3762:61 3760:. 3756:. 3730:. 3718:15 3716:. 3712:. 3675:. 3665:. 3653:. 3649:. 3626:. 3616:. 3604:22 3602:. 3598:. 3572:^ 3558:. 3548:. 3538:24 3536:. 3532:. 3509:. 3501:. 3487:. 3483:. 3460:. 3450:. 3438:. 3434:. 3422:^ 3408:. 3396:37 3394:. 3390:. 3367:. 3357:. 3345:. 3341:. 3318:. 3304:. 3300:. 3278:. 3268:. 3256:. 3252:. 3226:. 3214:^ 3186:^ 3172:. 3150:. 3140:. 3109:. 3101:. 3091:27 3089:. 3059:. 3047:65 3045:. 3041:. 3018:. 3008:. 2996:. 2992:. 2978:^ 2968:. 2945:^ 2919:. 2911:. 2895:. 2872:. 2864:. 2854:21 2852:. 2829:. 2821:. 2811:29 2809:. 2786:. 2776:. 2766:14 2764:. 2760:. 2737:. 2727:. 2717:68 2715:. 2711:. 2685:. 2675:. 2665:. 2653:. 2649:. 2626:. 2614:. 2590:. 2576:. 2572:. 2549:. 2539:. 2529:37 2527:. 2523:. 2500:. 2490:. 2480:. 2449:. 2441:. 2427:. 2423:. 2400:. 2390:17 2388:. 2365:. 2353:36 2351:. 2347:. 2324:. 2314:. 2304:78 2302:. 2298:. 2275:. 2267:. 2255:38 2253:. 2249:. 2226:. 2216:. 2206:79 2204:. 2200:. 2177:. 2167:. 2157:79 2155:. 2151:. 2128:. 2118:11 2116:. 2037:. 2027:. 2017:43 2015:. 2011:. 1963:. 1953:. 1943:65 1941:. 1937:. 1914:. 1906:. 1896:41 1894:. 1872:, 1862:, 1831:. 1821:. 1809:. 1805:. 1760:. 1750:. 1740:25 1738:. 1734:. 1711:. 1701:. 1693:. 1681:27 1679:. 1675:. 1663:^ 1649:. 1641:. 1633:. 1623:62 1621:. 1617:. 1593:. 1583:17 1581:. 1577:. 1552:. 1542:. 1522:^ 1508:. 1498:. 1486:26 1484:. 1480:. 1457:. 1447:. 1437:35 1435:. 1431:. 1406:56 1404:. 1381:. 1371:. 1361:. 1349:. 1345:. 1307:. 1297:. 1283:. 1279:. 777:, 727:. 596:. 588:, 502:, 485:. 477:, 113:, 101:. 7602:) 7598:( 7587:e 7580:t 7573:v 7401:) 7397:( 7386:) 7382:( 7312:) 7294:( 7289:/ 7280:) 7266:( 7261:/ 7218:: 6897:/ 6879:) 6854:e 6847:t 6840:v 6772:/ 6685:: 6681:/ 6648:: 6644:/ 6592:: 6564:/ 6552:/ 6532:) 6528:( 6465:) 6461:( 6425:) 6419:) 6415:( 6406:( 6385:) 6381:( 6371:) 6367:/ 6358:/ 6349:/ 6345:( 6289:) 6264:e 6257:t 6250:v 6222:° 5810:° 5804:° 5798:° 5787:° 5771:° 5755:° 5652:) 5648:( 5626:: 5622:/ 5544:: 5540:/ 5492:° 5486:° 5423:) 5419:( 5328:) 5324:( 5316:) 5308:( 5300:) 5283:( 5275:) 5271:( 5259:) 5255:( 5226:) 5204:e 5197:t 5190:v 5103:) 5101:V 5099:( 5074:) 5072:S 5070:( 5056:1 5054:H 5032:) 5030:R 5028:( 4844:) 4842:N 4840:( 4784:) 4782:M 4780:( 4774:, 4739:) 4735:( 4687:) 4683:( 4628:) 4624:( 4611:) 4605:P 4601:J 4599:( 4544:) 4542:H 4540:( 4504:) 4502:G 4500:( 4459:) 4457:D 4455:( 4345:) 4343:C 4341:( 4281:) 4279:B 4215:2 4213:H 4196:) 4194:A 4192:( 4168:e 4161:t 4154:v 4137:. 4112:. 4087:. 4068:. 4053:. 4017:. 3993:: 3985:: 3958:. 3934:: 3928:4 3907:. 3895:: 3872:. 3868:: 3817:. 3801:: 3774:. 3768:: 3740:. 3724:: 3683:. 3661:: 3634:. 3610:: 3566:. 3544:: 3517:. 3495:: 3468:. 3446:: 3440:2 3416:. 3402:: 3375:. 3353:: 3326:. 3312:: 3306:3 3286:. 3264:: 3237:. 3208:. 3158:. 3136:: 3117:. 3097:: 3074:. 3053:: 3026:. 3004:: 2939:. 2907:: 2901:8 2880:. 2860:: 2837:. 2817:: 2794:. 2772:: 2745:. 2723:: 2693:. 2669:: 2661:: 2655:6 2634:. 2622:: 2598:. 2584:: 2557:. 2535:: 2508:. 2476:: 2457:. 2435:: 2408:. 2396:: 2373:. 2359:: 2332:. 2310:: 2283:. 2261:: 2234:. 2212:: 2185:. 2163:: 2136:. 2124:: 2101:. 2086:. 2045:. 2023:: 1996:. 1971:. 1949:: 1922:. 1902:: 1858:: 1839:. 1817:: 1811:2 1790:. 1768:. 1746:: 1719:. 1687:: 1657:. 1629:: 1601:. 1589:: 1562:. 1538:: 1516:. 1492:: 1465:. 1443:: 1416:. 1389:. 1365:: 1357:: 1315:. 1291:: 1264:. 753:( 652:) 269:) 263:( 258:) 254:( 244:· 237:· 230:· 223:· 196:. 131:B 123:C 30:. 23:.

Index

Antiviral (disambiguation)
Antiviral Therapy (journal)

medication
viral infections
viruses
broad-spectrum antiviral
antimicrobials
antibiotic
antifungal
antiparasitic
monoclonal antibodies
treat
infections
virucides
eucalyptus
Australian tea trees
HIV
herpes viruses
hepatitis B
C
influenza A
B
AIDS
herpes viruses
trial-and-error
side effects
genetic sequences

verification

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑